Menu
Back to Journals » Infection and Drug Resistance
Infection and Drug Resistance
- View all (531)
- Volume 11, 2018 (261)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- 531 records -
Community-acquired methicillin-resistant Staphylococcus aureus from ST1 lineage harboring a new SCCmec IV subtype (SCCmec IVm) containing the tetK gene
Côrtes MF, Botelho AMN, Almeida LGP, Souza RC, Cunha ODL, Nicolás MF, Vasconcelos ATR, Figueiredo AMS
Infection and Drug Resistance 2018, 11:2583-2592
Published Date: 14 December 2018
An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017
Gao K, Guan X, Zeng L, Qian J, Zhu S, Deng Q, Zhong H, Pang S, Gao F, Wang J, Long Y, Chang C, Liu H
Infection and Drug Resistance 2018, 11:2561-2569
Published Date: 10 December 2018
Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan
Lai CC, Chen CC, Lu YC, Chen HJ, Su BA, Weng TC, Chiu YH, Toh HS, Zhang CC, Chiang SR, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:2555-2560
Published Date: 7 December 2018
Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies
Ranjbar R, Chehelgerdi M
Infection and Drug Resistance 2018, 11:2545-2554
Published Date: 13 December 2018
Vancomycin in the treatment of adult intra-abdominal infections: do we have strong evidences?
Liu S, Wang M, Guan W
Infection and Drug Resistance 2018, 11:2539-2543
Published Date: 7 December 2018
The association between platelet indices and deep surgical site infection after open induction internal fixation for traumatic limb fractures
Zhang Z, Ji Y, Wang Z, Qiu X, Chen Y
Infection and Drug Resistance 2018, 11:2533-2538
Published Date: 6 December 2018
Prevalence of nontuberculous mycobacteria and high efficacy of D-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus
Khosravi AD, Mirsaeidi M, Farahani A, Tabandeh MR, Mohajeri P, Shoja S, Hoseini Lar KhosroShahi SR
Infection and Drug Resistance 2018, 11:2521-2532
Published Date: 7 December 2018
Infection control perception and behavior: a question of sex and gender? Results of the AHOI feasibility study
Goerig T, Dittmann K, Kramer A, Diedrich S, Heidecke CD, Huebner NO
Infection and Drug Resistance 2018, 11:2511-2519
Published Date: 4 December 2018
Methicillin-resistant Staphylococcus aureus: livestock-associated, antimicrobial, and heavy metal resistance
Dweba CC, Zishiri OT, El Zowalaty ME
Infection and Drug Resistance 2018, 11:2497-2509
Published Date: 28 November 2018
Whole genome sequence analysis of NDM-1, CMY-4, and SHV-12 coproducing Salmonella enterica serovar Typhimurium isolated from a case of fatal burn wound infection
Banerjee K, Sekar P, Krishnan P, Wattam AR, Roy S, Hays JP, Menezes GA
Infection and Drug Resistance 2018, 11:2491-2495
Published Date: 28 November 2018
The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection
Zhou Y, Lin PC, Ye JR, Su SS, Dong L, Wu Q, Xu HY, Xie YP, Li YP
Infection and Drug Resistance 2018, 11:2483-2490
Published Date: 28 November 2018
Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai [Erratum]
Tian D, Pan F, Wang C, Sun Y, Zhang H
Infection and Drug Resistance 2018, 11:2481-2482
Published Date: 28 November 2018
Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia
Lee CH, Chen IL, Li CC, Chien CC
Infection and Drug Resistance 2018, 11:2471-2480
Published Date: 27 November 2018
Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China
Cai K, Wang Y, Guo Z, Xu X, Li H, Zhang Q
Infection and Drug Resistance 2018, 11:2461-2469
Published Date: 26 November 2018
Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment
Lausch KR, Søgaard M, Rosenvinge FS, Johansen HK, Boysen T, Røder BL, Mortensen KL, Nielsen L, Lemming L, Olesen B, Leitz C, Kristensen L, Dzajic E, Østergaard LJ, Schønheyder HC, Arendrup MC
Infection and Drug Resistance 2018, 11:2449-2459
Published Date: 23 November 2018
A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections
Tulasidas S, Rao P, Bhat S, Manipura R
Infection and Drug Resistance 2018, 11:2443-2448
Published Date: 23 November 2018
Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
Abo-Amer YE, Abd-Elsalam S, Eldosoky H, ELShenawy AK, Awny S, Elagawy W, El Abgeegy M, Elsergany HF, Elashry H, Negm MS
Infection and Drug Resistance 2018, 11:2435-2441
Published Date: 22 November 2018
Fecal carriage and phylo-diversity of community-acquired blaTEM Enteric bacilli in Southwest Nigeria
Akinduti PA, Olasehinde GI, Ejilude O, Taiwo OS, Obafemi YD
Infection and Drug Resistance 2018, 11:2425-2433
Published Date: 27 November 2018
Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017
Wang SJ, Liu XW, Shen X, Hua XG, Cui L
Infection and Drug Resistance 2018, 11:2411-2424
Published Date: 22 November 2018
Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis
Chen M, Pan H, Lou Y, Wu Z, Zhang J, Huang Y, Yu W, Qiu Y
Infection and Drug Resistance 2018, 11:2397-2409
Published Date: 20 November 2018
Vancomycin trough level and loading dose
Tuon FF, Romero R, Gasparetto J, Cieslinski J
Infection and Drug Resistance 2018, 11:2393-2396
Published Date: 23 November 2018
Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
Srivastava S, Kamthania M, Singh S, Saxena AK, Sharma N
Infection and Drug Resistance 2018, 11:2377-2391
Published Date: 21 November 2018
A molecular epidemiological study of methicillin-resistant and methicillin-susceptible Staphylococcus aureus contamination in the airport environment
Chen Z, Han C, Huang X, Liu Y, Guo D, Ye X
Infection and Drug Resistance 2018, 11:2363-2375
Published Date: 20 November 2018
Pomegranate extract specifically inhibits Clostridium difficile growth and toxin production without disturbing the beneficial bacteria in vitro
Sukumar MR, König B
Infection and Drug Resistance 2018, 11:2357-2362
Published Date: 16 November 2018
Pseudomonas aeruginosa bacteremia among liver transplant recipients
Liu TH, Zhang YZ, Wan QQ
Infection and Drug Resistance 2018, 11:2345-2356
Published Date: 16 November 2018
Which methods are appropriate for the detection of Staphylococcus argenteus and is it worthwhile to distinguish S. argenteus from S. aureus?
Kaden R, Engstrand L, Rautelin H, Johansson C
Infection and Drug Resistance 2018, 11:2335-2344
Published Date: 21 November 2018
Health care-associated infections – an overview
Haque M, Sartelli M, McKimm J, Abu Bakar M
Infection and Drug Resistance 2018, 11:2321-2333
Published Date: 15 November 2018
A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) 2007–2016
Zhang J, Zhao C, Chen H, Li H, Wang Q, Wang Z, Zhang F, Wang H
Infection and Drug Resistance 2018, 11:2311-2319
Published Date: 15 November 2018
Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection
Wang JL, Kuo CF, Yeh CM, Chen JR, Cheng MF, Hung CH
Infection and Drug Resistance 2018, 11:2301-2310
Published Date: 15 November 2018
Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments
Eze EC, Chenia HY, El Zowalaty ME
Infection and Drug Resistance 2018, 11:2277-2299
Published Date: 15 November 2018
Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran
Moosavian M, Ghadri H, Samli Z
Infection and Drug Resistance 2018, 11:2269-2275
Published Date: 15 November 2018
Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia
Almughais ES, Alfarhan A, Salam M
Infection and Drug Resistance 2018, 11:2257-2267
Published Date: 15 November 2018
Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China
Wang Y, Zhang R, Liu W
Infection and Drug Resistance 2018, 11:2249-2255
Published Date: 13 November 2018
Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment
Wang Q, Zhang P, Zhao D, Jiang Y, Zhao F, Wang Y, Li X, Du X, Yu Y
Infection and Drug Resistance 2018, 11:2241-2248
Published Date: 13 November 2018
The inflammasome in leprosy skin lesions: an immunohistochemical evaluation
Silva LM, de Sousa JR, Hirai KE, Dias LB Jr, Furlaneto IP, Oliveira Carneiro FR, de Souza Aarão TL, Sotto MN, Quaresma JAS
Infection and Drug Resistance 2018, 11:2231-2240
Published Date: 12 November 2018
Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing
Al-Ghafli H, Kohl TA, Merker M, Varghese B, Halees A, Niemann S, Al-Hajoj S
Infection and Drug Resistance 2018, 11:2219-2229
Published Date: 12 November 2018
First reported nosocomial outbreak of Serratia marcescens harboring blaIMP-4 and blaVIM-2 in a neonatal intensive care unit in Cairo, Egypt
Ghaith DM, Zafer MM, Ismail DK, Al-Agamy MH, Bohol MFF, Al-Qahtani A, Al-Ahdal MN, Elnagdy SM, Mostafa IY
Infection and Drug Resistance 2018, 11:2211-2217
Published Date: 8 November 2018
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Perales C, Chen Q, Soria ME, Gregori J, Garcia-Cehic D, Nieto-Aponte L, Castells L, Imaz A, Llorens-Revull M, Domingo E, Buti M, Esteban JI, Rodriguez-Frias F, Quer J
Infection and Drug Resistance 2018, 11:2207-2210
Published Date: 8 November 2018
Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners
Bianco A, Papadopoli R, Mascaro V, Pileggi C, Pavia M
Infection and Drug Resistance 2018, 11:2199-2205
Published Date: 8 November 2018
Extensively drug-resistant Acinetobacter baumannii and Proteeae association in a Romanian intensive care unit: risk factors for acquisition
Muntean D, Licker M, Horhat F, Dumitrașcu V, Săndesc D, Bedreag O, Dugăeșescu D, Coșniță DA, Krasta A, Bădițoiu L
Infection and Drug Resistance 2018, 11:2187-2197
Published Date: 8 November 2018
Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B
Wang L, Chen P, Zheng C
Infection and Drug Resistance 2018, 11:2179-2185
Published Date: 8 November 2018
Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital, Northwest Ethiopia
Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT
Infection and Drug Resistance 2018, 11:2169-2178
Published Date: 8 November 2018
Molecular characteristics and comparative genomics analysis of a clinical Enterococcus casseliflavus with a resistance plasmid
Yin M, Jiang Y, Qian C, Wu F, Ying Y, Wu C, Li P, Ying J, Li K, Xu T, Bao Q, Sun C
Infection and Drug Resistance 2018, 11:2159-2167
Published Date: 5 November 2018
Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand
Bubpamala J, Khuntayaporn P, Thirapanmethee K, Montakantikul P, Santanirand P, Chomnawang MT
Infection and Drug Resistance 2018, 11:2151-2157
Published Date: 5 November 2018
Community acquired pneumonia among adult patients at an Egyptian university hospital: bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy
El-Sokkary RH, Ramadan RA, El-Shabrawy M, El-Korashi LA, Elhawary A, Embarak S, Tash RME, Elantouny NG
Infection and Drug Resistance 2018, 11:2141-2150
Published Date: 2 November 2018
Novel mechanism responsible for high-level macrolide resistance in Moraxella catarrhalis
Kasai A, Ohta A, Maeda Y, Yamada K, Tao K, Saito R
Infection and Drug Resistance 2018, 11:2137-2140
Published Date: 1 November 2018
The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
Xu RA, Gu EM, Liu TH, Ou-yang QG, Hu GX, Cai JP
Infection and Drug Resistance 2018, 11:2129-2135
Published Date: 1 November 2018
Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
Minosse C, Selleri M, Giombini E, Bartolini B, Capobianchi MR, Cerilli S, Loiacono L, Taibi C, D'Offizi G, McPhee F, Garbuglia AR
Infection and Drug Resistance 2018, 11:2117-2127
Published Date: 2 November 2018
In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus
Chen H, Li L, Liu Y, Wu M, Xu S, Zhang G, Qi C, Du Y, Wang M, Li J, Huang X
Infection and Drug Resistance 2018, 11:2107-2115
Published Date: 1 November 2018
Clinical features, risk factors, and impact of antibiotic treatment of diarrhea caused by Shigella in children less than 5 years in Manhiça District, rural Mozambique
Vubil D, Acácio S, Quintó L, Ballesté-Delpierre C, Nhampossa T, Kotloff K, Levine MM, Alonso P, Nataro JP, Farag TH, Vila J, Mandomando I
Infection and Drug Resistance 2018, 11:2095-2106
Published Date: 31 October 2018
Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis
Phillips CJ, Wisdom AJ, McKinnon RA, Woodman RJ, Gordon DL
Infection and Drug Resistance 2018, 11:2081-2094
Published Date: 31 October 2018
Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
Huang HT, Wang HM, Yang SC, Tai WC, Liang CM, Wu KL, Lee CH, Chuah SK
Infection and Drug Resistance 2018, 11:2073-2080
Published Date: 30 October 2018
Amputation of a finger in a patient with multidrug-resistant Mycobacterium marinum skin infection
Veraldi S, Pontini P, Nazzaro G
Infection and Drug Resistance 2018, 11:2069-2071
Published Date: 30 October 2018
Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant
Fujisawa J, Mutoh T, Kawamura K, Sawada N, Ono D, Yamaguchi T, Morioka I
Infection and Drug Resistance 2018, 11:2063-2067
Published Date: 31 October 2018
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
Ferstl PG, Müller M, Filmann N, Hogardt M, Kempf VAJ, Wichelhaus TA, Lange CM, Vermehren J, Zeuzem S, Reinheimer C, Waidmann O
Infection and Drug Resistance 2018, 11:2047-2061
Published Date: 2 November 2018
Molecular epidemiology of Pseudomonas aeruginosa in University Clinical Center of Kosovo
Lila G, Mulliqi G, Raka L, Kurti A, Bajrami R, Azizi E
Infection and Drug Resistance 2018, 11:2039-2046
Published Date: 26 October 2018
Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire
Toure OA, Landry TN, Assi SB, Kone AA, Gbessi EA, Ako BA, Coulibaly B, Kone B, Ouattara O, Beourou S, Koffi A, Remoue F, Rogier C
Infection and Drug Resistance 2018, 11:2031-2038
Published Date: 26 October 2018
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
Niu T, Xiao TT, Guo L, Yu W, Chen Y, Zheng B, Huang C, Yu X, Xiao Y
Infection and Drug Resistance 2018, 11:2021-2030
Published Date: 26 October 2018
Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
Tsai CY, Lee CH, Chen IL
Infection and Drug Resistance 2018, 11:2011-2020
Published Date: 26 October 2018
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
Yan L, Zhu C, Li J, Chen L, Ding Y, Cao Z, Liu K, Lin L, Tang W, Xie Q, Xu Y, Bao S, Wang H
Infection and Drug Resistance 2018, 11:2001-2009
Published Date: 29 October 2018
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
Tavares RCF, Feldner AC, Pinho JR, Malta FM, Carvalho-Filho RJ, Santana RA, Fusco Duarte de Castro V, Dastoli GT, Custódio Lima J, Ferraz ML
Infection and Drug Resistance 2018, 11:1993-2000
Published Date: 25 October 2018
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Jean SS, Lu MC, Shi ZY, Tseng SH, Wu TS, Lu PL, Shao PL, Ko WC, Wang FD, Hsueh PR
Infection and Drug Resistance 2018, 11:1983-1992
Published Date: 26 October 2018
Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections
Hogan M, Bridgeman MB, Min GH, Dixit D, Bridgeman PJ, Narayanan N
Infection and Drug Resistance 2018, 11:1975-1981
Published Date: 25 October 2018
Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH
Infection and Drug Resistance 2018, 11:1959-1974
Published Date: 25 October 2018
The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agents
Wu PP, He H, Hong WD, Wu TR, Huang GY, Zhong YY, Tu BR, Gao M, Zhou J, Zhao SQ, Li DL, Xu XT, Sheng ZJ, Ward SA, O’Neill PM, Zhang K
Infection and Drug Resistance 2018, 11:1945-1957
Published Date: 24 October 2018
Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai
Tian D, Pan F, Wang C, Sun Y, Zhang H
Infection and Drug Resistance 2018, 11:1935-1943
Published Date: 24 October 2018
Treatment-refractory giardiasis: challenges and solutions
Lalle M, Hanevik K
Infection and Drug Resistance 2018, 11:1921-1933
Published Date: 24 October 2018
Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings
Ekwanzala MD, Dewar JB, Kamika I, Momba MNB
Infection and Drug Resistance 2018, 11:1907-1920
Published Date: 17 October 2018
Selection inversion: a probable tool against antibiotic resistance
Baloch Z, Aslam B, Muzammil S, Khurshid M, Rasool MH, Ma K
Infection and Drug Resistance 2018, 11:1903-1905
Published Date: 18 October 2018
Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis
Qin F, Wang Q, Zhang C, Fang C, Zhang L, Chen H, Zhang M, Cheng F
Infection and Drug Resistance 2018, 11:1893-1901
Published Date: 17 October 2018
Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Jean SS, Lee WS, Hsueh PR
Infection and Drug Resistance 2018, 11:1881-1891
Published Date: 17 October 2018
The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
Davoudi-Monfared E, Khalili H
Infection and Drug Resistance 2018, 11:1831-1880
Published Date: 17 October 2018
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
Sirous M, Khosravi AD, Tabandeh MR, Salmanzadeh S, Ahmadkhosravi N, Amini S
Infection and Drug Resistance 2018, 11:1819-1829
Published Date: 18 October 2018
Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus
Jelinkova P, Splichal Z, Jimenez Jimenez AM, Haddad Y, Mazumdar A, Sur VP, Milosavljevic V, Kopel P, Buchtelova H, Guran R, Zitka O, Richtera L, Hegerova D, Heger Z, Moulick A, Adam V
Infection and Drug Resistance 2018, 11:1807-1817
Published Date: 12 October 2018
Tuberculosis of the parotid lymph nodes: clinical and imaging features
Zhang D, Li X, Xiong H, Yang C, Lv F, Huang X, Li Q, Tang Z, Luo T
Infection and Drug Resistance 2018, 11:1795-1805
Published Date: 11 October 2018
Comparative analysis of bla KPC-2- and rmtB-carrying IncFII-family pKPC-LK30/pHN7A8 hybrid plasmids from Klebsiella pneumoniae CG258 strains disseminated among multiple Chinese hospitals
Shi L, Feng J, Zhan Z, Zhao Y, Zhou H, Mao H, Gao Y, Zhang Y, Yin Z, Gao B, Tong Y, Luo Y, Zhang D, Zhou D
Infection and Drug Resistance 2018, 11:1783-1793
Published Date: 11 October 2018
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies
Pompilio A, Geminiani C, Mantini P, Siriwardena TN, Di Bonaventura I, Reymond JL, Di Bonaventura G
Infection and Drug Resistance 2018, 11:1767-1782
Published Date: 11 October 2018
A genomic infection control study for Staphylococcus aureus in two Ghanaian hospitals
Donkor ES, Jamrozy D, Mills RO, Dankwah T, Amoo PK, Egyir B, Badoe EV, Twasam J, Bentley SD
Infection and Drug Resistance 2018, 11:1757-1765
Published Date: 11 October 2018
Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017
Toledo-Rueda W, Rosas-Murrieta NH, Muñoz-Medina JE, González-Bonilla CR, Reyes-Leyva J, Santos-López G
Infection and Drug Resistance 2018, 11:1751-1756
Published Date: 11 October 2018
Detection of common mobile genetic elements and genotyping of multidrug-resistant Gram-negative bacilli in blood specimens from septicemia patients in southern China
Rui Y, Lu W, Li S, Cheng C, Sun J, Yang Q
Infection and Drug Resistance 2018, 11:1741-1750
Published Date: 12 October 2018
Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction
Jiang X, Deng A, Yang J, Bai H, Yang Z, Wu J, Lv H, Li X, Wen T
Infection and Drug Resistance 2018, 11:1729-1740
Published Date: 11 October 2018
Epidemiology of antibiotic resistance of blood culture in educational hospitals in Rasht, North of Iran
Keihanian F, Saeidinia A, Abbasi K, Keihanian F
Infection and Drug Resistance 2018, 11:1723-1728
Published Date: 10 October 2018
Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran
Nishida S, Ono Y
Infection and Drug Resistance 2018, 11:1715-1722
Published Date: 10 October 2018
Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia
Kobayashi D, Shindo Y, Ito R, Iwaki M, Okumura J, Sakakibara T, Yamaguchi I, Yagi T, Ogasawara T, Sugino Y, Taniguchi H, Saito H, Saka H, Kawamura T, Hasegawa Y
Infection and Drug Resistance 2018, 11:1703-1713
Published Date: 11 October 2018
Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils
Juárez-Ortega M, Rojas-Espinosa O, Muñiz-Salazar R, Becerril-Villanueva E, Hernández-Solís A, Arce-Paredes P, Islas-Trujillo S, Cicero-Sabido R
Infection and Drug Resistance 2018, 11:1685-1702
Published Date: 10 October 2018
Detection of Mycobacterium lepromatosis in patients with leprosy in India
Ahuja M, Lavania M, Singh I, Turankar RP, Chhabra S, Narang T, Dogra S, Sengupta U
Infection and Drug Resistance 2018, 11:1677-1683
Published Date: 10 October 2018
Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome
Lee CH, Chuah SK, Tai WC, Chen IL
Infection and Drug Resistance 2018, 11:1669-1676
Published Date: 9 October 2018
Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility
Xiao M, Chen SCA, Kong F, Fan X, Cheng JW, Hou X, Zhou ML, Wang H, Xu YC
Infection and Drug Resistance 2018, 11:1659-1667
Published Date: 9 October 2018
Antibiotic resistance: a rundown of a global crisis
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MKF, Baloch Z
Infection and Drug Resistance 2018, 11:1645-1658
Published Date: 10 October 2018
Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
Su M, Liao L, Xing H, Wang S, Li Y, Lu W, He L, Deng J, Shao Y, Li T, Zhuang H
Infection and Drug Resistance 2018, 11:1635-1644
Published Date: 2 October 2018
Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China
Jian J, Yang X, Yang J, Chen L
Infection and Drug Resistance 2018, 11:1627-1634
Published Date: 1 October 2018
Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria
Molina-Moya B, Abdurrahman ST, Madukaji LI, Gomgnimbou MK, Spinasse L, Gomes-Fernandes M, Gomes HM, Kacimi S, Dacombe R, Bimba JS, Lawson L, Sola C, Cuevas LE, Dominguez J
Infection and Drug Resistance 2018, 11:1617-1625
Published Date: 1 October 2018
Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance
Rizk MA, AbouLaila M, El-Sayed SAE, Guswanto A, Yokoyama N, Igarashi I
Infection and Drug Resistance 2018, 11:1605-1615
Published Date: 28 September 2018
Prevalence and molecular characteristics of mcr-1 colistin resistance in Escherichia coli: isolates of clinical infection from a Chinese University Hospital
Cao L, Li X, Xu Y, Shen J
Infection and Drug Resistance 2018, 11:1597-1603
Published Date: 26 September 2018
Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
Lim TP, Wang R, Poh GQ, Koh TH, Tan TY, Lee W, Teo JQ, Cai Y, Tan TT, Ee PLR, Kwa AL
Infection and Drug Resistance 2018, 11:1591-1596
Published Date: 27 September 2018
Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo Zone, Southern Ethiopia
Wondale B, Medhin G, Abebe G, Tolosa S, Mohammed T, Teklu T, Pieper R, Ameni G
Infection and Drug Resistance 2018, 11:1581-1589
Published Date: 25 September 2018
Evaluation of blood culture broths with lysis buffer to directly identify specific pathogens by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry methods
Hariu M, Watanabe Y, Oikawa N, Manaka T, Seki M
Infection and Drug Resistance 2018, 11:1573-1579
Published Date: 24 September 2018
Effects of oral probiotic supplementation on gut Lactobacillus and Bifidobacterium populations and the clinical status of low-birth-weight preterm neonates: a multicenter randomized, double-blind, placebo-controlled trial
Strus M, Helwich E, Lauterbach R, Rzepecka-Węglarz B, Nowicka K, Wilińska M, Szczapa J, Rudnicka M, Sławska H, Szczepański M, Waśko A, Mikołajczyk-Cichońska A, Tomusiak-Plebanek A, Heczko PB
Infection and Drug Resistance 2018, 11:1557-1571
Published Date: 21 September 2018
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
Ashu EE, Korfanty GA, Samarasinghe H, Pum N, You M, Yamamura D, Xu J
Infection and Drug Resistance 2018, 11:1549-1555
Published Date: 20 September 2018
Trichosporon dohaense, a rare pathogen of human invasive infections, and literature review
Yu SY, Guo LN, Xiao M, Kudinha T, Kong F, Wang H, Cheng JW, Zhou ML, Xu H, Xu YC
Infection and Drug Resistance 2018, 11:1537-1547
Published Date: 20 September 2018
Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital
López-García A, Rocha-Gracia RC, Bello-López E, Juárez-Zelocualtecalt C, Sáenz Y, Castañeda-Lucio M, López-Pliego L, González-Vázquez C, Torres C, Ayala-Nuñez T, Jiménez-Flores G, Arenas-Hernández MP, Lozano-Zarain P
Infection and Drug Resistance 2018, 11:1523-1536
Published Date: 20 September 2018
Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents [Corrigendum]
D'Accolti M, Soffritti I, Piffanelli M, Bisi M, Mazzacane S, Caselli E
Infection and Drug Resistance 2018, 11:1521-1522
Published Date: 20 September 2018
Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia
Arega B, Woldeamanuel Y, Adane K, Sherif AA, Asrat D
Infection and Drug Resistance 2018, 11:1511-1519
Published Date: 18 September 2018
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
Atkin SD, Abid S, Foster M, Bose M, Keller A, Hollaway R, Sader HS, Greenberg DE, Finklea JD, Castanheira M, Jain R
Infection and Drug Resistance 2018, 11:1499-1510
Published Date: 17 September 2018
Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy
Wu YP, Li XD, Ke ZB, Chen SH, Chen PZ, Wei Y, Huang JB, Sun XL, Xue XY, Zheng QS, Xu N
Infection and Drug Resistance 2018, 11:1491-1497
Published Date: 17 September 2018
First molecular characterization of related cases of healthcare-associated infections involving multidrug-resistant Enterococcus faecium vanA in Algeria
Benammar S, Pantel A, Aujoulat F, Benmehidi M, Courcol R, Lavigne JP, Romano-Bertrand S, Marchandin H
Infection and Drug Resistance 2018, 11:1483-1490
Published Date: 17 September 2018
Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis
Xiao G, Chen Z, Lv X
Infection and Drug Resistance 2018, 11:1473-1481
Published Date: 13 September 2018
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
Petty LA, Henig O, Patel TS, Pogue JM, Kaye KS
Infection and Drug Resistance 2018, 11:1461-1472
Published Date: 12 September 2018
Comparative genomics of five different resistance plasmids coexisting in a clinical multi-drug resistant Citrobacter freundii isolate
Ouyang J, Sun F, Zhou D, Feng J, Zhan Z, Xiong Z, Yang B, Liu Z, Li T, Tong Y, Xia P
Infection and Drug Resistance 2018, 11:1447-1460
Published Date: 12 September 2018
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
Lai CC, Chen CC, Lu YC, Lin TP, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:1441-1445
Published Date: 11 September 2018
Better drugs for Lyme disease: focus on the spirochete
Stricker RB, Middelveen MJ
Infection and Drug Resistance 2018, 11:1437-1439
Published Date: 7 September 2018
Assessing health burden risk and control effect on dengue fever infection in the southern region of Taiwan
Cheng YH, Lin YJ, Chen SC, You SH, Chen WY, Hsieh NH, Yang YF, Liao CM
Infection and Drug Resistance 2018, 11:1423-1435
Published Date: 6 September 2018
Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal
Naidoo K, Dookie N, Naidoo K, Yende-Zuma N, Chimukangara B, Bhushan A, Govender D, Gengiah S, Padayatchi N
Infection and Drug Resistance 2018, 11:1413-1421
Published Date: 5 September 2018
A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile
Brosio F, Masetti G, Matteo G, Stefanati A, Gabutti G
Infection and Drug Resistance 2018, 11:1401-1411
Published Date: 5 September 2018
Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016
Shoji H, Vázquez-Sánchez DA, Gonzalez-Diaz A, Cubero M, Tubau F, Santos S, García-Somoza D, Liñares J, Yuste J, Martí S, Ardanuy C
Infection and Drug Resistance 2018, 11:1387-1400
Published Date: 4 September 2018
In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study
Almaaytah A, Albalas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:1383-1386
Published Date: 3 September 2018
Benchmarking for surgical site infections among gastrointestinal surgeries and related risk factors: multicenter study in Kuwait
Hamza WS, Salama MF, Morsi SS, Abdo NM, Al-Fadhli MA
Infection and Drug Resistance 2018, 11:1373-1381
Published Date: 3 September 2018
Efficacy of intraventricular amikacin treatment in pan-resistant Pseudomonas aeruginosa postsurgical meningitis
Molinaro M, Morelli P, De Gregori M, De Gregori S, Giardini I, Tordato F, Monzillo V, Pocaterra D, Casari E
Infection and Drug Resistance 2018, 11:1369-1372
Published Date: 3 September 2018
Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey)
Robineau O, Robert J, Rabaud C, Bedos JP, Varon E, Péan Y, Gauzit R, Alfandari S
Infection and Drug Resistance 2018, 11:1359-1368
Published Date: 31 August 2018
Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS) hospitals
Zhou ML, Wang Y, Liu C, Kudinha T, Liu X, Luo Y, Yang QW, Sun H, Hu J, Xu YC
Infection and Drug Resistance 2018, 11:1347-1358
Published Date: 30 August 2018
Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study
Tian X, Sun S, Jia X, Zou H, Li S, Zhang L
Infection and Drug Resistance 2018, 11:1339-1346
Published Date: 29 August 2018
Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014
Voumbo-Matoumona DF, Kouna LC, Madamet M, Maghendji-Nzondo S, Pradines B, Lekana-Douki JB
Infection and Drug Resistance 2018, 11:1329-1338
Published Date: 28 August 2018
The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice
Xu LN, Xu RA, Zhang D, Su SS, Xu HY, Wu Q, Li YP
Infection and Drug Resistance 2018, 11:1321-1328
Published Date: 27 August 2018
Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015
Santerre Henriksen A, Smart JI, Hamed K
Infection and Drug Resistance 2018, 11:1309-1320
Published Date: 28 August 2018
Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies
Guo D, Liu Y, Han C, Chen Z, Ye X
Infection and Drug Resistance 2018, 11:1299-1307
Published Date: 23 August 2018
Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
Zhang J, Liu Y, Nie X, Yu Y, Gu J, Zhao L
Infection and Drug Resistance 2018, 11:1283-1297
Published Date: 22 August 2018
Application of tuf gene sequence analysis for the identification of species of coagulase-negative staphylococci in clinical samples and evaluation of their antimicrobial resistance pattern
Khosravi AD, Roointan M, Abbasi Montazeri E, Aslani S, Hashemzadeh M, Taheri Soodejani M
Infection and Drug Resistance 2018, 11:1275-1282
Published Date: 22 August 2018
Two residues in Staphylococcus aureus α-hemolysin related to hemolysis and self-assembly
Du Y, Liu L, Zhang C, Zhang Y
Infection and Drug Resistance 2018, 11:1271-1274
Published Date: 21 August 2018
Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations
Ramadan RA, Gebriel MG, Kadry HM, Mosallam A
Infection and Drug Resistance 2018, 11:1261-1269
Published Date: 22 August 2018
Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
Asif M, Alvi IA, Rehman SU
Infection and Drug Resistance 2018, 11:1249-1260
Published Date: 21 August 2018
Genetic polymorphisms of exon 1 of MBL2 contribute to tuberculosis risk especially in Asian populations: an updated meta-analysis of 26 studies
Wu YJ, Yang X, Chen TD, Zhang ZX, You YZ, Fan ZD
Infection and Drug Resistance 2018, 11:1237-1248
Published Date: 20 August 2018
Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
Li S, Jia X, Li C, Zou H, Liu H, Guo Y, Zhang L
Infection and Drug Resistance 2018, 11:1225-1235
Published Date: 20 August 2018
Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
Ngamprasertchai T, Boonyasiri A, Charoenpong L, Nimitvilai S, Lorchirachoonkul N, Wattanamongkonsil L, Thamlikitkul V
Infection and Drug Resistance 2018, 11:1219-1224
Published Date: 20 August 2018
Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
Tsai CY, Lee CH, Chien CC, Chen IL
Infection and Drug Resistance 2018, 11:1205-1217
Published Date: 15 August 2018
Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
Hung YP, Tsai PJ, Lee YT, Tang HJ, Lin HJ, Liu HC, Lee JC, Tsai BY, Hsueh PR, Ko WC
Infection and Drug Resistance 2018, 11:1197-1203
Published Date: 15 August 2018
Detection and characterization of a clinical Escherichia coli ST3204 strain coproducing NDM-16 and MCR-1
Li X, Mu X, Zhang P, Zhao D, Ji J, Quan J, Zhu Y, Yu Y
Infection and Drug Resistance 2018, 11:1189-1195
Published Date: 15 August 2018
Insertion element mediated mgrB disruption and presence of ISKpn28 in colistin-resistant Klebsiella pneumoniae isolates from Saudi Arabia
Uz Zaman T, Albladi M, Siddique MI, Aljohani SM, Balkhy HH
Infection and Drug Resistance 2018, 11:1183-1187
Published Date: 15 August 2018
Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
Huang YT, Liao CH, Chen SY, Yang CJ, Hsu HS, Teng LJ, Hsueh PR
Infection and Drug Resistance 2018, 11:1175-1182
Published Date: 14 August 2018
Identification of key genes and pathways using bioinformatics analysis in septic shock children
Yang J, Zhang S, Zhang J, Dong J, Wu J, Zhang L, Guo P, Tang S, Zhao Z, Wang H, Zhao Y, Zhang W, Wu F
Infection and Drug Resistance 2018, 11:1163-1174
Published Date: 14 August 2018
Co-production of MCR-1 and NDM-5 in Escherichia coli isolated from a colonization case of inpatient
Feng S, Shen C, Chen H, Zheng X, Xia Y, Zhong LL, Huang X, Wu X, Tian GB
Infection and Drug Resistance 2018, 11:1157-1161
Published Date: 14 August 2018
Plasmodium knowlesi malaria: current research perspectives
Amir A, Cheong FW, de Silva JR, Liew JWK, Lau YL
Infection and Drug Resistance 2018, 11:1145-1155
Published Date: 10 August 2018
Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
Hsieh MH, Lin CY, Wang CY, Fang YF, Lo YL, Lin SM, Lin HC
Infection and Drug Resistance 2018, 11:1137-1143
Published Date: 10 August 2018
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
Bonsall D, Black S, Howe AYM, Chase R, Ingravallo P, Pak I, Brown A, Smith DA, Bowden R, Barnes E
Infection and Drug Resistance 2018, 11:1119-1135
Published Date: 8 August 2018
Optimal infusion rate in antimicrobial therapy: explosion of evidence in the last five years
Zhu LL, Zhou Q
Infection and Drug Resistance 2018, 11:1105-1117
Published Date: 8 August 2018
Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran
Amin M, Sirous M, Javaherizadeh H, Motamedifar M, Saki M, Veisi H, Ebrahimi S, Seyed-Mohammadi S, Hashemzadeh M
Infection and Drug Resistance 2018, 11:1097-1104
Published Date: 8 August 2018
Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
Jiang Z, He X, Li J
Infection and Drug Resistance 2018, 11:1083-1095
Published Date: 7 August 2018
Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections
Shime N, Saito N, Bokui M, Sakane N, Kamimura M, Shinohara T, Kosaka T, Ishikura H, Kobayashi A
Infection and Drug Resistance 2018, 11:1073-1081
Published Date: 6 August 2018
HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
Tsai HC, Chen IT, Lee SS, Chen YS
Infection and Drug Resistance 2018, 11:1061-1071
Published Date: 3 August 2018
The rs1625579 T>G polymorphism in the miRNA-137 gene confers a risk of early-onset Kawasaki disease in a southern Chinese population
Che D, Li J, Fu L, Pi L, Rong X, Wang Y, Xu Y, Huang P, Chu M, Gu X
Infection and Drug Resistance 2018, 11:1055-1060
Published Date: 3 August 2018
Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland
Król-Turmińska K, Olender A
Infection and Drug Resistance 2018, 11:1047-1053
Published Date: 6 August 2018
Sacroiliitis and osteomyelitis caused by serotype 3 Streptococcus pneumoniae in a previously healthy adult: a case report
Hadano Y, Chang B
Infection and Drug Resistance 2018, 11:1043-1046
Published Date: 3 August 2018
High prevalence of hypervirulent Klebsiella pneumoniae infection in the genetic background of elderly patients in two teaching hospitals in China
Liu C, Shi J, Guo J
Infection and Drug Resistance 2018, 11:1031-1041
Published Date: 31 July 2018
Extremely high levels of vancomycin can cause severe renal toxicity
Barceló-Vidal J, Rodríguez-García E, Grau S
Infection and Drug Resistance 2018, 11:1027-1030
Published Date: 30 July 2018
Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents
D'Accolti M, Soffritti I, Piffanelli M, Bisi M, Mazzacane S, Caselli E
Infection and Drug Resistance 2018, 11:1015-1026
Published Date: 30 July 2018
The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections
Azargun R, Sadeghi MR, Soroush Barhaghi MH, Samadi Kafil H, Yeganeh F, Ahangar Oskouee M, Ghotaslou R
Infection and Drug Resistance 2018, 11:1007-1014
Published Date: 23 July 2018
ISEcp1-mediated transposition of chromosome-borne blaCMY-2 into an endogenous ColE1-like plasmid in Escherichia coli
Fang LX, Li XP, Li L, Chen MY, Wu CY, Li LL, Liao XP, Liu YH, Sun J
Infection and Drug Resistance 2018, 11:995-1005
Published Date: 23 July 2018
Pathogenesis and management of adenoviral keratoconjunctivitis
Chigbu DI, Labib BA
Infection and Drug Resistance 2018, 11:981-993
Published Date: 17 July 2018
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action
Ciociola T, Giovati L, Giovannelli A, Conti S, Castagnola M, Vitali A
Infection and Drug Resistance 2018, 11:969-979
Published Date: 17 July 2018
Current perspectives on diagnosis and management of sternal wound infections
Yusuf E, Chan M, Renz N, Trampuz A
Infection and Drug Resistance 2018, 11:961-968
Published Date: 16 July 2018
Identifying differentially expressed long non-coding RNAs in PBMCs in response to the infection of multidrug-resistant tuberculosis
Yan H, Xu R, Zhang XR, Wang Q, Pang J, Zhang X, Chang X, Zhang Y
Infection and Drug Resistance 2018, 11:945-959
Published Date: 13 July 2018
Effect of ethanol pretreatment in Acanthamoeba keratitis: a long-term follow-up study
Lin IH, Tseng SH, Huang FC, Huang YH
Infection and Drug Resistance 2018, 11:937-943
Published Date: 5 July 2018
Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique
Guiral E, Pons MJ, Vubil D, Marí-Almirall M, Sigaúque B, Soto SM, Alonso PL, Ruiz J, Vila J, Mandomando I
Infection and Drug Resistance 2018, 11:927-936
Published Date: 3 July 2018
Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates
de Alteriis E, Maselli V, Falanga A, Galdiero S, Di Lella FM, Gesuele R, Guida M, Galdiero E
Infection and Drug Resistance 2018, 11:915-925
Published Date: 3 July 2018
Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction
García-Carnero LC, Pérez-García LA, Martínez-Álvarez JA, Reyes-Martínez JE, Mora-Montes HM
Infection and Drug Resistance 2018, 11:903-913
Published Date: 3 July 2018
Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AA, Ameen HH
Infection and Drug Resistance 2018, 11:895-901
Published Date: 27 June 2018
Mutation EthAW21R confers co-resistance to protionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
Mugweru J, Liu J, Makafe G, Chiwala G, Wang B, Wang C, Li X, Tan Y, Yew WW, Tan S, Zhang T
Infection and Drug Resistance 2018, 11:891-894
Published Date: 13 June 2018
The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS) [Retraction]
Nakstad B
Infection and Drug Resistance 2018, 11:889-890
Published Date: 12 June 2018
Association between tobacco smoking and drug-resistant tuberculosis
Wang MG, Huang WW, Wang Y, Zhang YX, Zhang MM, Wu SQ, Sandford AJ, He JQ
Infection and Drug Resistance 2018, 11:873-887
Published Date: 12 June 2018
Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality
Martín-Aspas A, Guerrero-Sánchez FM, García-Colchero F, Rodríguez-Roca S, Girón-González JA
Infection and Drug Resistance 2018, 11:861-872
Published Date: 6 June 2018
Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in Taiwan: a multicenter cohort study
Cheng CY, Tsai MS, Yang CJ, Cheng SH, Sun HY, Chang SF, Su LH, Su YC, Hung CC, Chang SY
Infection and Drug Resistance 2018, 11:849-859
Published Date: 5 June 2018
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:835-847
Published Date: 1 June 2018
Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan
Hirano R, Sakamoto Y, Kitazawa J, Yamamoto S, Kayaba H
Infection and Drug Resistance 2018, 11:821-833
Published Date: 31 May 2018
Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation
Yeoh SF, Lee TJ, Chew KL, Lin S, Yeo D, Setia S
Infection and Drug Resistance 2018, 11:805-819
Published Date: 30 May 2018
Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations
Tohamy ST, Aboshanab KM, El-Mahallawy HA, El-Ansary MR, Afifi SS
Infection and Drug Resistance 2018, 11:791-803
Published Date: 25 May 2018
Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints
Kuti JL, Wang Q, Chen H, Li H, Wang H, Nicolau DP
Infection and Drug Resistance 2018, 11:783-790
Published Date: 25 May 2018
Dose-response associations of methicillin-resistant Staphylococcus aureus between school environmental contamination and nasal carriage by elementary students
Lin J, Liang J, Zhang T, Bai C, Ye J, Yao Z
Infection and Drug Resistance 2018, 11:773-782
Published Date: 24 May 2018
Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review
Jansåker F, Frimodt-Møller N, Benfield TL, Knudsen JD
Infection and Drug Resistance 2018, 11:761-771
Published Date: 24 May 2018
Majocchi’s granuloma: current perspectives
Boral H, Durdu M, Ilkit M
Infection and Drug Resistance 2018, 11:751-760
Published Date: 22 May 2018
Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients
Licker M, Sorescu T, Rus M, Cirlea N, Horhat F, Jurescu C, Botoca M, Cumpănaș A, Timar R, Muntean D
Infection and Drug Resistance 2018, 11:743-749
Published Date: 18 May 2018
Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
Bourafa N, Chaalal W, Bakour S, Lalaoui R, Boutefnouchet N, Diene SM, Rolain JM
Infection and Drug Resistance 2018, 11:735-742
Published Date: 17 May 2018
Plasma-activated water: a new and effective alternative for duodenoscope reprocessing
Bălan GG, Roșca I, Ursu EL, Doroftei F, Bostănaru AC, Hnatiuc E, Năstasă V, Șandru V, Ștefănescu G, Trifan A, Mareș M
Infection and Drug Resistance 2018, 11:727-733
Published Date: 17 May 2018
Expression patterns of oxyR induced by oxidative stress from Porphyromonas gingivalis in response to photo-activated disinfection
Pourhajibagher M, Ghorbanzadeh R, Bahador A
Infection and Drug Resistance 2018, 11:717-725
Published Date: 15 May 2018
Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections
Yuan XH, Liu T, Wu D, Wan QQ
Infection and Drug Resistance 2018, 11:707-715
Published Date: 14 May 2018
Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
Kuwahara-Ota S, Chinen Y, Mizuno Y, Takimoto-Shimomura T, Matsumura-Kimoto Y, Tanba K, Tsukamoto T, Mizutani S, Shimura Y, Kobayashi T, Horiike S, Kuroda J
Infection and Drug Resistance 2018, 11:701-705
Published Date: 14 May 2018
Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
Kostera J, Leckie G, Abravaya K, Wang H
Infection and Drug Resistance 2018, 11:695-699
Published Date: 11 May 2018
Seasonality of cellulitis: evidence from Google Trends
Zhang X, Dang S, Ji F, Shi J, Li Y, Li M, Jia X, Wan Y, Bao X, Wang W
Infection and Drug Resistance 2018, 11:689-693
Published Date: 3 May 2018
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:681-687
Published Date: 3 May 2018
Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B
Li H, Zhang L, Ren H, Hu P
Infection and Drug Resistance 2018, 11:671-680
Published Date: 3 May 2018
Comparative genomic analysis of multidrug-resistant Streptococcus pneumoniae isolates
Pan F, Zhang H, Dong X, Ye W, He P, Zhang SL, Zhu JX, Zhong N
Infection and Drug Resistance 2018, 11:659-670
Published Date: 3 May 2018
Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality
Liu T, Zhang Y, Wan QQ
Infection and Drug Resistance 2018, 11:647-658
Published Date: 3 May 2018
Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study
Liu L, Liu B, Li Y, Zhang W
Infection and Drug Resistance 2018, 11:637-646
Published Date: 1 May 2018
Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study
Duszynska W, Litwin A, Rojek S, Szczesny A, Ciasullo A, Gozdzik W
Infection and Drug Resistance 2018, 11:629-635
Published Date: 1 May 2018
A case of Lyme disease in a Japanese woman
Seki M, Watanabe Y, Kawabata H
Infection and Drug Resistance 2018, 11:625-628
Published Date: 26 April 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project
Bagella P, De Socio GVL, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G
Infection and Drug Resistance 2018, 11:615-623
Published Date: 26 April 2018
Comparative evaluation of methods for the detection of biofilm formation in coagulase-negative staphylococci and correlation with antibiogram
Shrestha LB, Bhattarai NR, Khanal B
Infection and Drug Resistance 2018, 11:607-613
Published Date: 24 April 2018
A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality
Xiao T, Yu W, Niu T, Huang C, Xiao Y
Infection and Drug Resistance 2018, 11:595-606
Published Date: 24 April 2018
Ambulance vehicles as a source of multidrug-resistant infections: a multicenter study in Assiut City, Egypt
El-Mokhtar MA, Hetta HF
Infection and Drug Resistance 2018, 11:587-594
Published Date: 24 April 2018
In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae
Yu W, Luo Q, Shi Q, Huang C, Yu X, Niu T, Zhou K, Zhang J, Xiao Y
Infection and Drug Resistance 2018, 11:577-585
Published Date: 24 April 2018
Antimicrobial use of reactive oxygen therapy: current insights
Memar MY, Ghotaslou R, Samiei M, Adibkia K
Infection and Drug Resistance 2018, 11:567-576
Published Date: 24 April 2018
A prospective cohort study of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus carriage in neonates: the role of maternal carriage and phenotypic and molecular characteristics
Lin J, Wu C, Yan C, Ou Q, Lin D, Zhou J, Ye X, Yao Z
Infection and Drug Resistance 2018, 11:555-565
Published Date: 24 April 2018
Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults
Maharjan A, Bhetwal A, Shakya S, Satyal D, Shah S, Joshi G, Khanal PR, Parajuli NP
Infection and Drug Resistance 2018, 11:547-554
Published Date: 26 April 2018
Antibiotic sensitivities of coagulase-negative staphylococci and Staphylococcus aureus in hip and knee periprosthetic joint infections: does this differ if patients meet the International Consensus Meeting Criteria?
De Vecchi E, George DA, Romanò CL, Pregliasco FE, Mattina R, Drago L
Infection and Drug Resistance 2018, 11:539-546
Published Date: 13 April 2018
Characterization of enterotoxin A-producing Staphylococcus aureus
Chen D, Song Q, Xu Z, Zhang D
Infection and Drug Resistance 2018, 11:531-538
Published Date: 13 April 2018
Understanding antibiotic resistance via outer membrane permeability
Ghai I, Ghai S
Infection and Drug Resistance 2018, 11:523-530
Published Date: 11 April 2018
Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates
Pang H, Wan K, Wei L
Infection and Drug Resistance 2018, 11:515-521
Published Date: 9 April 2018
Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics
Chernysh S, Gordya N, Tulin D, Yakovlev A
Infection and Drug Resistance 2018, 11:501-514
Published Date: 9 April 2018
Molecular epidemiology of Clostridium difficile in two tertiary care hospitals in Shandong Province, China
Luo Y, Zhang W, Cheng JW, Xiao M, Sun GR, Guo CJ, Liu MJ, Cong PS, Kudinha T
Infection and Drug Resistance 2018, 11:489-500
Published Date: 6 April 2018
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
Righi E, Carnelutti A, Vena A, Bassetti M
Infection and Drug Resistance 2018, 11:479-488
Published Date: 4 April 2018
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
Cai S, Li Z, Yu T, Xia M, Peng J
Infection and Drug Resistance 2018, 11:469-477
Published Date: 3 April 2018
Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii
Zhang Y, Li Z, He X, Ding F, Wu W, Luo Y, Fan B, Cao H
Infection and Drug Resistance 2018, 11:457-467
Published Date: 29 March 2018
Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar
Khan M, Ahmed J, Gul A, Ikram A, Lalani FK
Infection and Drug Resistance 2018, 11:447-456
Published Date: 28 March 2018
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
Ahmed OA, Elsebaey MA, Fouad MHA, Elashry H, Elshafie AI, Elhadidy AA, Esheba NE, Elnaggar MH, Soliman S, Abd-Elsalam S
Infection and Drug Resistance 2018, 11:441-445
Published Date: 28 March 2018
Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones
Sun H, Zeng J, Li S, Liang P, Zheng C, Liu Y, Luo T, Rastogi N, Sun Q
Infection and Drug Resistance 2018, 11:431-440
Published Date: 27 March 2018
Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
Singh BR
Infection and Drug Resistance 2018, 11:427-429
Published Date: 22 March 2018
A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections
Tong Q, Hammer KDP, Johnson EM, Zegarra M, Goto M, Lo TS
Infection and Drug Resistance 2018, 11:417-425
Published Date: 16 March 2018
Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis
Tariq R, Mukhija D, Gupta A, Singh S, Pardi DS, Khanna S
Infection and Drug Resistance 2018, 11:405-416
Published Date: 13 March 2018
Vertical transmission of group B Streptococcus and associated factors among pregnant women: a cross-sectional study, Eastern Ethiopia
Yadeta TA, Worku A, Egata G, Seyoum B, Marami D, Berhane Y
Infection and Drug Resistance 2018, 11:397-404
Published Date: 13 March 2018
Carriage of colistin-resistant, extended-spectrum β-lactamase-producing Escherichia coli harboring the mcr-1 resistance gene after short-term international travel to Vietnam
Nakayama T, Kumeda Y, Kawahara R, Yamaguchi T, Yamamoto Y
Infection and Drug Resistance 2018, 11:391-395
Published Date: 12 March 2018
A case of Brucella melitensis endocarditis in a patient with cardiovascular implantable electronic device
Al-Adsani W, Ahmad A, Al-Mousa M
Infection and Drug Resistance 2018, 11:387-390
Published Date: 9 March 2018
Multicenter prospective study on the prevalence of colistin resistance in Escherichia coli: relevance of mcr-1-positive clinical isolates in Lombardy, Northern Italy
Principe L, Piazza A, Mauri C, Anesi A, Bracco S, Brigante G, Casari E, Agrappi C, Caltagirone M, Novazzi F, Migliavacca R, Pagani L, Luzzaro F
Infection and Drug Resistance 2018, 11:377-385
Published Date: 9 March 2018
Patient autonomy and disclosure of material information about hospital-acquired infections
Hostiuc S, Molnar AJ, Moldoveanu A, Aluaș M, Moldoveanu F, Bocicor I, Dascalu MI, Bădilă E, Hostiuc M, Negoi I
Infection and Drug Resistance 2018, 11:369-375
Published Date: 7 March 2018
The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS)
Nakstad B
Infection and Drug Resistance 2018, 11:359-368
Published Date: 8 March 2018
Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China
Zhao JL, Liu W, Xie WY, Cao XD, Yuan L
Infection and Drug Resistance 2018, 11:345-358
Published Date: 6 March 2018
Health-seeking behavior and transmission dynamics in the control of influenza infection among different age groups
You SH, Chen SC, Liao CM
Infection and Drug Resistance 2018, 11:331-343
Published Date: 6 March 2018
Clustering and recent transmission of Mycobacterium tuberculosis in a Chinese population
Xu G, Mao X, Wang J, Pan H
Infection and Drug Resistance 2018, 11:323-330
Published Date: 6 March 2018
Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
Martínez-Casanova J, Carballo N, Luque S, Sorli L, Grau S
Infection and Drug Resistance 2018, 11:317-321
Published Date: 5 March 2018
New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China
Peng L, Xu Z, Huo Z, Long R, Ma L
Infection and Drug Resistance 2018, 11:307-315
Published Date: 5 March 2018
Multidrug-resistant malaria and the impact of mass drug administration
Zuber JA, Takala-Harrison S
Infection and Drug Resistance 2018, 11:299-306
Published Date: 1 March 2018
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
Ahmed OA, Kaisar HH, Badawi R, Hawash N, Samir H, Shabana SST, Fouad MHA, Rizk FH, Khodeir SA, Abd-Elsalam S
Infection and Drug Resistance 2018, 11:295-298
Published Date: 1 March 2018
Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score
Chen IL, Lee CH, Ting SW, Wang LY
Infection and Drug Resistance 2018, 11:283-293
Published Date: 1 March 2018
Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
Nguyen KV, Nguyen TV, Nguyen HTT, Le DV
Infection and Drug Resistance 2018, 11:275-282
Published Date: 28 February 2018
Overview of the development of quinolone resistance in Salmonella species in China, 2005–2016
Song Q, Xu Z, Gao H, Zhang D
Infection and Drug Resistance 2018, 11:267-274
Published Date: 26 February 2018
Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
Lee C, Chen I, Li CC, Chien C
Infection and Drug Resistance 2018, 11:257-266
Published Date: 23 February 2018
Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients
Garbacz K, Piechowicz L, Podkowik M, Mroczkowska A, Empel J, Bania J
Infection and Drug Resistance 2018, 11:247-255
Published Date: 22 February 2018
Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
Osei-Wusu S, Amo Omari M, Asante-Poku A, Darko Otchere I, Asare P, Forson A, Otu J, Antonio M, Yeboah-Manu D
Infection and Drug Resistance 2018, 11:239-246
Published Date: 22 February 2018
Effect of MRSA on CYP450: dynamic changes of cytokines, oxidative stress, and drug-metabolizing enzymes in mice infected with MRSA
Tang HQ, Long NN, Lin L, Liu Y, Li JL, Sun FH, Guo LJ, Zhang F, Dai M
Infection and Drug Resistance 2018, 11:229-238
Published Date: 13 February 2018
High-dose amikacin for achieving serum target levels in critically ill elderly patients
Sadeghi K, Hamishehkar H, Najmeddin F, Ahmadi A, Hazrati E, Honarmand H, Mojtahedzadeh M
Infection and Drug Resistance 2018, 11:223-228
Published Date: 13 February 2018
Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation
Netsvyetayeva I, Marusza W, Olszanski R, Szyller K, Krolak-Ulinska A, Swoboda-Kopec E, Sierdzinski J, Szymonski Z, Mlynarczyk G
Infection and Drug Resistance 2018, 11:213-222
Published Date: 12 February 2018
Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area
Nayar DS
Infection and Drug Resistance 2018, 11:205-211
Published Date: 31 January 2018
Salmonella enterica serovars Typhimurium and Enteritidis causing mixed infections in febrile children in Mozambique
García V, Mandomando I, Ruiz J, Herrera-León S, Alonso PL, Rodicio MR
Infection and Drug Resistance 2018, 11:195-204
Published Date: 31 January 2018
The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis
Xia L, Li SF, Shao K, Zhang X, Huang S
Infection and Drug Resistance 2018, 11:187-193
Published Date: 30 January 2018
Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies
Fiore M, Cascella M, Bimonte S, Maraolo AE, Gentile I, Schiavone V, Pace MC
Infection and Drug Resistance 2018, 11:177-186
Published Date: 26 January 2018
Enriched whole genome sequencing identified compensatory mutations in the RNA polymerase gene of rifampicin-resistant Mycobacterium leprae strains
Lavania M, Singh I, Turankar RP, Gupta AK, Ahuja M, Pathak V, Sengupta U
Infection and Drug Resistance 2018, 11:169-175
Published Date: 25 January 2018
Imported melioidosis in Japan: a review of cases
Hadano Y
Infection and Drug Resistance 2018, 11:163-168
Published Date: 24 January 2018
Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
Xiao M, Fan X, Hou X, Chen SCA, Wang H, Kong F, Sun ZY, Chu YZ, Xu YC
Infection and Drug Resistance 2018, 11:155-161
Published Date: 23 January 2018
Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis
Lv L, Li T, Xu K, Shi P, He B, Kong W, Wang J, Sun J
Infection and Drug Resistance 2018, 11:147-154
Published Date: 23 January 2018
Knowledge of community pharmacists about antibiotics, and their perceptions and practices regarding antimicrobial stewardship: a cross-sectional study in Punjab, Pakistan
Sarwar MR, Saqib A, Iftikhar S, Sadiq T
Infection and Drug Resistance 2018, 11:133-145
Published Date: 18 January 2018
Timing of antibiotic administration and lactate measurement in septic shock patients: a comparison between hospital wards and the emergency department
Vattanavanit V, Buppodom T, Khwannimit B
Infection and Drug Resistance 2018, 11:125-132
Published Date: 18 January 2018
Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
Lin L, Chang S, Ge M, Liu T, Lu J
Infection and Drug Resistance 2018, 11:113-123
Published Date: 18 January 2018
Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
Huang C, Zheng B, Yu W, Niu T, Xiao T, Zhang J, Xiao Y
Infection and Drug Resistance 2018, 11:103-112
Published Date: 15 January 2018
Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001–2010 in Kolkata, India: role of integrons, plasmids, and topoisomerase mutations
Rajpara N, Nair M, Chowdhury G, Mukhopadhyay AK, Ramamurthy T, Niyogi SK, Bhardwaj AK
Infection and Drug Resistance 2018, 11:87-102
Published Date: 12 January 2018
Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics
Bucki R, Durnaś B, Wątek M, Piktel E, Cruz K, Wolak P, Savage PB, Janmey PA
Infection and Drug Resistance 2018, 11:77-86
Published Date: 11 January 2018
Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
Gokarn K, Pal RB
Infection and Drug Resistance 2018, 11:61-75
Published Date: 9 January 2018
Distribution of sasX, pvl, and qacA/B genes in epidemic methicillin-resistant Staphylococcus aureus strains isolated from East China
Kong H, Fang L, Jiang R, Tong J
Infection and Drug Resistance 2018, 11:55-59
Published Date: 9 January 2018
Multilocus sequence typing and variations in the oprD gene of Pseudomonas aeruginosa isolated from a hospital in China
Liu H, Kong W, Yang W, Chen G, Liang H, Zhang Y
Infection and Drug Resistance 2018, 11:45-54
Published Date: 8 January 2018
Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia
Alkabab YM, Enani MA, Indarkiri NY, Heysell SK
Infection and Drug Resistance 2018, 11:37-43
Published Date: 3 January 2018
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections
Zhou L, Gao Y, Cao W, Liu J, Guan H, Zhang H, Shi Y, Lv W, Cheng L
Infection and Drug Resistance 2018, 11:29-36
Published Date: 5 January 2018
An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines
Awad LS, Abdallah DI, Mugharbil AM, Jisr TH, Droubi NS, El-Rajab NA, Moghnieh RA
Infection and Drug Resistance 2018, 11:17-28
Published Date: 22 December 2017
Surgical release for tubercular elbow stiffness
Qian Y, Han Q, Wang W, Ouyang Y, Yuan W, Fan C
Infection and Drug Resistance 2018, 11:9-16
Published Date: 22 December 2017
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
Mac Donald-Ottevanger MS, Adhin MR, Jitan JK, Bretas G, Vreden SGS
Infection and Drug Resistance 2018, 11:3-8
Published Date: 20 December 2017
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
Al-Saeedi M, Al-Hajoj S
Infection and Drug Resistance 2018, 11:1-2
Published Date: 20 December 2017
Potential and use of bacterial small RNAs to combat drug resistance: a systematic review
Chan H, Ho J, Liu X, Zhang L, Wong SH, Chan MT, Wu WK
Infection and Drug Resistance 2017, 10:521-532
Published Date: 15 December 2017
Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis
Lv Y, Han F, Jia Y, Wan Z, Gong L, Liu H, Liu L
Infection and Drug Resistance 2017, 10:511-519
Published Date: 14 December 2017
Naturally occurring genotypic drug-resistant mutations of HBV in Huzhou, China: a single-center study
Qian F, Zou W, Qin J, Li D
Infection and Drug Resistance 2017, 10:507-509
Published Date: 14 December 2017
Performance of VITEK mass spectrometry V3.0 for rapid identification of clinical Aspergillus fumigatus in different culture conditions based on ribosomal proteins
Zhou L, Chen Y, Xu Y
Infection and Drug Resistance 2017, 10:499-506
Published Date: 8 December 2017
Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt
Helmy OM, Kashef MT
Infection and Drug Resistance 2017, 10:479-498
Published Date: 8 December 2017
Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait
Sonnevend Á, Yahfoufi N, Ghazawi A, Jamal W, Rotimi V, Pál T
Infection and Drug Resistance 2017, 10:469-478
Published Date: 6 December 2017
Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
Ruiz P, Causse M, Vaquero M, Gutierrez JB, Casal M
Infection and Drug Resistance 2017, 10:463-467
Published Date: 6 December 2017
Molecular evaluation of colistin-resistant gene expression changes in Acinetobacter baumannii with real-time polymerase chain reaction
Sepahvand S, Davarpanah MA, Roudgari A, Bahador A, Karbasizade V, Kargar Jahromi Z
Infection and Drug Resistance 2017, 10:455-462
Published Date: 27 November 2017
Association between the IL-6 gene polymorphism and tuberculosis risk: a meta-analysis
Wang H, Pang C, Zeng N, Wan C, Shen Y, Wen F
Infection and Drug Resistance 2017, 10:445-454
Published Date: 27 November 2017
In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital
Lertsrisatit Y, Santimaleeworagun W, Thunyaharn S, Traipattanakul J
Infection and Drug Resistance 2017, 10:437-443
Published Date: 20 November 2017
Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance
Bengyella L, Yekwa EL, Subhani MN, Tambo E, Nawaz K, Hetsa BA, Iftikhar S, Waikhom SD, Roy P
Infection and Drug Resistance 2017, 10:425-436
Published Date: 7 November 2017
Right and left ventricular function in hospitalized children with respiratory syncytial virus infection
Horter T, Nakstad B, Ashtari O, Solevåg AL
Infection and Drug Resistance 2017, 10:419-424
Published Date: 7 November 2017
Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials
Tucker H, Wible M, Gandhi A, Quintana A
Infection and Drug Resistance 2017, 10:401-417
Published Date: 3 November 2017
Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children
Polat M, Kara SS
Infection and Drug Resistance 2017, 10:393-399
Published Date: 1 November 2017
Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China
Li Z, Chen Z, Li H, Ren H, Hu P
Infection and Drug Resistance 2017, 10:377-392
Published Date: 31 October 2017
Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value
D'Ostroph AR, So TY
Infection and Drug Resistance 2017, 10:365-375
Published Date: 19 October 2017
Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities
El-Sokkary RH, Tash RME, Meawed TE, El Seifi OS, Mortada EM
Infection and Drug Resistance 2017, 10:357-364
Published Date: 17 October 2017
Correlation between resistance mechanisms in Staphylococcus aureus and cell wall and septum thickening
García AB, Viñuela-Prieto JM, López-González L, Candel FJ
Infection and Drug Resistance 2017, 10:353-356
Published Date: 17 October 2017
High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014
Tsai HC, Chen IT, Wu KS, Tseng YT, Sy CL, Chen JK, Lee SS, Chen YS
Infection and Drug Resistance 2017, 10:343-352
Published Date: 16 October 2017
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
Al-Saeedi M, Al-Hajoj S
Infection and Drug Resistance 2017, 10:333-342
Published Date: 13 October 2017
National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China
Xiao M, Cheng JW, Kudinha T, Kong F, Xu YC
Infection and Drug Resistance 2017, 10:329-331
Published Date: 13 October 2017
Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece
Kritsotakis EI, Kontopidou F, Astrinaki E, Roumbelaki M, Ioannidou E, Gikas A
Infection and Drug Resistance 2017, 10:317-328
Published Date: 10 October 2017
Investigating a rare methicillin-resistant Staphylococcus aureus strain: first description of genome sequencing and molecular characterization of CC15-MRSA
Senok AC, Somily AM, Slickers P, Raji MA, Garaween G, Shibl A, Monecke S, Ehricht R
Infection and Drug Resistance 2017, 10:307-315
Published Date: 4 October 2017
Diagnostic accuracy of Xpert MTB/RIF assay for musculoskeletal tuberculosis: a meta-analysis
Wen H, Li P, Ma H, Lv G
Infection and Drug Resistance 2017, 10:299-305
Published Date: 28 September 2017
Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients
Katip W, Uitrakul S, Oberdorfer P
Infection and Drug Resistance 2017, 10:293-298
Published Date: 7 September 2017
Mycoplasma genitalium infections: current treatment options and resistance issues
Sethi S, Zaman K, Jain N
Infection and Drug Resistance 2017, 10:283-292
Published Date: 1 September 2017
Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients
Chen Z, Pang X, Li Z, Ren H, Hu P
Infection and Drug Resistance 2017, 10:275-281
Published Date: 31 August 2017
Exploring bacterial outer membrane barrier to combat bad bugs
Ghai I, Ghai S
Infection and Drug Resistance 2017, 10:261-273
Published Date: 30 August 2017
Antifungal resistance: current trends and future strategies to combat
Wiederhold NP
Infection and Drug Resistance 2017, 10:249-259
Published Date: 29 August 2017
Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]
Nicolau DP, Silberg BN
Infection and Drug Resistance 2017, 10:247-248
Published Date: 16 August 2017
Fluconazole resistance in Candida species: a current perspective
Berkow EL, Lockhart SR
Infection and Drug Resistance 2017, 10:237-245
Published Date: 31 July 2017
Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi
Qamar S, Shaheen N, Shakoor S, Farooqi J, Jabeen K, Hasan R
Infection and Drug Resistance 2017, 10:231-236
Published Date: 31 July 2017
Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections
Nicolau DP, Silberg BN
Infection and Drug Resistance 2017, 10:227-230
Published Date: 26 July 2017
Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies
Hsieh NH, Lin YJ, Yang YF, Liao CM
Infection and Drug Resistance 2017, 10:215-226
Published Date: 20 July 2017
Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia
Assefa D, Seyoum B, Oljira L
Infection and Drug Resistance 2017, 10:209-213
Published Date: 11 July 2017
Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B
Pacheco SR, Santos MIMA, Stocker A, Zarife MAS, Schinoni MI, Paraná R, Reis MG, Silva LK
Infection and Drug Resistance 2017, 10:201-207
Published Date: 5 July 2017
Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
Chong Y, Shimoda S, Miyake N, Aoki T, Ito Y, Kamimura T, Shimono N
Infection and Drug Resistance 2017, 10:193-199
Published Date: 27 June 2017
Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B
Infection and Drug Resistance 2017, 10:185-192
Published Date: 14 June 2017
Prevalence and antibiotic resistance of coagulase-negative Staphylococci isolated from poultry farms in three regions of Ghana
Boamah VE, Agyare C, Odoi H, Adu F, Gbedema SY, Dalsgaard A
Infection and Drug Resistance 2017, 10:175-183
Published Date: 13 June 2017
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
Jaksuwan R, Tharavichikul P, Patumanond J, Chuchottaworn C, Chanwong S, Smithtikarn S, Settakorn J
Infection and Drug Resistance 2017, 10:167-174
Published Date: 10 June 2017
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Sarma S, Upadhyay S
Infection and Drug Resistance 2017, 10:155-165
Published Date: 7 June 2017
Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic
Carlson JM, Leonard AB, Hyde ER, Petrosino JF, Primm TP
Infection and Drug Resistance 2017, 10:143-154
Published Date: 9 May 2017
Uniform-related infection control practices of dental students
Aljohani Y, Almutadares M, Alfaifi K, El Madhoun M, Albahiti MH, Al-Hazmi N
Infection and Drug Resistance 2017, 10:135-142
Published Date: 24 April 2017
Drug resistance in influenza A virus: the epidemiology and management
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M
Infection and Drug Resistance 2017, 10:121-134
Published Date: 20 April 2017
Usefulness of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify pathogens, including polymicrobial samples, directly from blood culture broths
Hariu M, Watanabe Y, Oikawa N, Seki M
Infection and Drug Resistance 2017, 10:115-120
Published Date: 19 April 2017
In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil
Freitas LS, Almeida NCC, Freitas Queiroz MA, Zaninotto MM, Fuzii HT, Ribeiro-Silva A, Vallinoto ACR, Ishak MOG, Quaresma JAS, Ishak R
Infection and Drug Resistance 2017, 10:109-114
Published Date: 10 April 2017
The "black evil" affecting patients with diabetes: a case of rhino orbito cerebral mucormycosis causing Garcin syndrome
Narayanan S, Panarkandy G, Subramaniam G, Radhakrishnan C, Thulaseedharan NK, Manikath N, Ramaswamy S, Radhakrishnan S, Ekkalayil D
Infection and Drug Resistance 2017, 10:103-108
Published Date: 28 March 2017
Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India
Harichandran D, Dinesh KR
Infection and Drug Resistance 2017, 10:97-101
Published Date: 14 March 2017
Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study
Workicho A, Kassahun W, Alemseged F
Infection and Drug Resistance 2017, 10:91-96
Published Date: 13 March 2017
Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru
Boehnke KF, Valdivieso M, Bussalleu A, Sexton R, Thompson KC, Osorio S, Novoa Reyes I, Crowley JJ, Baker LH, Xi C
Infection and Drug Resistance 2017, 10:85-90
Published Date: 10 March 2017
Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia
Brhane M, Kebede A, Petros Y
Infection and Drug Resistance 2017, 10:75-83
Published Date: 9 March 2017
Effect of a small molecule Lipid II binder on bacterial cell wall stress
Malin J, Shetty AC, Daugherty SC, de Leeuw EPH
Infection and Drug Resistance 2017, 10:69-73
Published Date: 28 February 2017
Post-influenza aspergillosis, do not underestimate influenza B
Nulens EF, Bourgeois MJ, Reynders MB
Infection and Drug Resistance 2017, 10:61-67
Published Date: 21 February 2017
Cerebral malaria: insight into pathogenesis, complications and molecular biomarkers
Yusuf FH, Hafiz MY, Shoaib M, Ahmed SA
Infection and Drug Resistance 2017, 10:57-59
Published Date: 2 February 2017
Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia
Althaqafi AO, Matar MJ, Moghnieh R, Alothman AF, Alenazi TH, Farahat F, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM
Infection and Drug Resistance 2017, 10:49-55
Published Date: 2 February 2017
Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia
Matar MJ, Moghnieh R, Alothman AF, Althaqafi AO, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Haider S, Stephens JM
Infection and Drug Resistance 2017, 10:43-48
Published Date: 3 February 2017
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon
Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM
Infection and Drug Resistance 2017, 10:35-41
Published Date: 2 February 2017
Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children
Legese MH, Weldearegay GM, Asrat D
Infection and Drug Resistance 2017, 10:27-34
Published Date: 25 January 2017
Occurrence of extended-spectrum and AmpC β-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria
Akinyemi KO, Iwalokun BA, Oyefolu AOB, Fakorede CO
Infection and Drug Resistance 2017, 10:19-25
Published Date: 13 January 2017
Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar’i N, Al-Balas Q
Infection and Drug Resistance 2017, 10:1-17
Published Date: 29 December 2016
A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
Sallam MM, Abou-Aisha K, El-Azizi M
Infection and Drug Resistance 2016, 9:301-311
Published Date: 8 December 2016
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
Natesan SK, Chandrasekar PH
Infection and Drug Resistance 2016, 9:291-300
Published Date: 7 December 2016
Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis
Lau CSM, Ward A, Chamberlain RS
Infection and Drug Resistance 2016, 9:275-289
Published Date: 7 December 2016
Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians
Spiekerman KM, Patel SJ, Patel R, Kociolek LK
Infection and Drug Resistance 2016, 9:269-274
Published Date: 5 December 2016
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
Vreden SGS, Bansie RD, Jitan JK, Adhin MR
Infection and Drug Resistance 2016, 9:261-267
Published Date: 24 November 2016
The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A
Infection and Drug Resistance 2016, 9:253-260
Published Date: 22 November 2016
Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience
Hirano R, Sakamoto Y, Kitazawa J, Yamamoto S, Tachibana N
Infection and Drug Resistance 2016, 9:243-252
Published Date: 14 October 2016
Evaluating vancomycin susceptibility in Staphylococcus aureus
Mimica MJ, Navarini A
Infection and Drug Resistance 2016, 9:239-241
Published Date: 26 September 2016
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
Burgel PR, Paugam A, Hubert D, Martin C
Infection and Drug Resistance 2016, 9:229-238
Published Date: 20 September 2016
Lemierre’s syndrome: current perspectives on diagnosis and management
Johannesen KM, Bodtger U
Infection and Drug Resistance 2016, 9:221-227
Published Date: 14 September 2016
Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
Stricker RB, Johnson L
Infection and Drug Resistance 2016, 9:215-219
Published Date: 13 September 2016
Peramivir injection in the treatment of acute influenza: a review of the literature
Wester A, Shetty AK
Infection and Drug Resistance 2016, 9:201-214
Published Date: 22 August 2016
Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:199-200
Published Date: 23 August 2016
Pelvic inflammatory disease: improving awareness, prevention, and treatment
Das BB, Ronda J, Trent M
Infection and Drug Resistance 2016, 9:191-197
Published Date: 19 August 2016
Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro
El-Azizi M, Khardori N
Infection and Drug Resistance 2016, 9:181-189
Published Date: 19 August 2016
Early detection of neonatal group B streptococcus sepsis and the possible diagnostic utility of IL-6, IL-8, and CD11b in a human umbilical cord blood in vitro model
Nakstad B, Sonerud T, Solevåg AL
Infection and Drug Resistance 2016, 9:171-179
Published Date: 8 July 2016
Strategies for prevention of ultrasound-guided prostate biopsy infections
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:161-169
Published Date: 8 July 2016
Emerging resistant serotypes of invasive Streptococcus pneumoniae
Elshafie S, Taj-Aldeen SJ
Infection and Drug Resistance 2016, 9:153-160
Published Date: 29 June 2016
Concern over Zika virus outbreak: another alarming global threat
Hafiz MY, Mahmood SU, Shoaib M, Yusuf FH
Infection and Drug Resistance 2016, 9:149-151
Published Date: 28 June 2016
An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes
Thabit AK, Nicolau DP
Infection and Drug Resistance 2016, 9:143-148
Published Date: 27 June 2016
Optimal management of genital herpes: current perspectives
Sauerbrei A
Infection and Drug Resistance 2016, 9:129-141
Published Date: 13 June 2016
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
Jones TM, Johnson SW, DiMondi VP, Wilson DT
Infection and Drug Resistance 2016, 9:119-128
Published Date: 7 June 2016
Conceptual framework for outcomes research studies of hepatitis C: an analytical review
Sbarigia U, Denee TR, Turner NG, Wan GJ, Morrison A, Kaufman AS, Rice G, Dusheiko GM
Infection and Drug Resistance 2016, 9:101-117
Published Date: 27 May 2016
Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients
Yuhashi K, Yagihara Y, Misawa Y, Sato T, Saito R, Okugawa S, Moriya K
Infection and Drug Resistance 2016, 9:93-99
Published Date: 27 May 2016
Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
Phillips CJ, Wells NA, Martinello M, Smith S, Woodman RJ, Gordon DL
Infection and Drug Resistance 2016, 9:87-92
Published Date: 31 May 2016
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
Donnelley MA, Zhu ES, Thompson GR 3rd
Infection and Drug Resistance 2016, 9:79-86
Published Date: 2 June 2016
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
Watters CM, Burton T, Kirui DK, Millenbaugh NJ
Infection and Drug Resistance 2016, 9:71-78
Published Date: 27 April 2016
Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
Hawkshead III JJ, Van Dyke RB, Hassig SE, Webber LS, Begue RE
Infection and Drug Resistance 2016, 9:59-70
Published Date: 18 April 2016
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Gonzalez-Ruiz A, Seaton RA, Hamed K
Infection and Drug Resistance 2016, 9:47-58
Published Date: 15 April 2016
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Rustomjee R, Zumla A
Infection and Drug Resistance 2016, 9:43-45
Published Date: 1 April 2016
Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature
Chipolombwe J, Török ME, Mbelle N, Nyasulu P
Infection and Drug Resistance 2016, 9:35-42
Published Date: 12 February 2016
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus
Potashman MH, Stokes M, Liu J, Lawrence R, Harris L
Infection and Drug Resistance 2016, 9:19-33
Published Date: 28 January 2016
Pseudomonas aeruginosa ventilator-associated pneumonia management
Ramírez-Estrada S, Borgatta B, Rello J
Infection and Drug Resistance 2016, 9:7-18
Published Date: 20 January 2016
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
Gupta AK, Daigle D
Infection and Drug Resistance 2016, 9:1-6
Published Date: 18 January 2016
Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana
Opintan JA, Newman MJ, Arhin RE, Donkor ES, Gyansa-Lutterodt M, Mills-Pappoe W
Infection and Drug Resistance 2015, 8:379-389
Published Date: 18 November 2015
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
Brigden G, Hewison C, Varaine F
Infection and Drug Resistance 2015, 8:367-378
Published Date: 30 October 2015
Delamanid expanded access novel treatment of drug resistant tuberculosis
Rustomjee R, Zumla A
Infection and Drug Resistance 2015, 8:359-366
Published Date: 29 October 2015
Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection
Hagiya H, Tasaka K, Sendo T, Otsuka F
Infection and Drug Resistance 2015, 8:353-357
Published Date: 20 October 2015
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Taha H, Das A, Das S
Infection and Drug Resistance 2015, 8:339-352
Published Date: 1 October 2015
Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm
Crowther GS, Wilcox MH
Infection and Drug Resistance 2015, 8:333-337
Published Date: 15 September 2015
Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
Soysal A
Infection and Drug Resistance 2015, 8:321-331
Published Date: 9 September 2015
Modeling human influenza infection in the laboratory
Radigan KA, Misharin AV, Chi M, Scott Budinger GR
Infection and Drug Resistance 2015, 8:311-320
Published Date: 31 August 2015
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
Zmarlicka MT, Nailor MD, Nicolau DP
Infection and Drug Resistance 2015, 8:297-309
Published Date: 24 August 2015
Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria
Russotto V, Cortegiani A, Graziano G, Saporito L, Raineri SM, Mammina C, Giarratano A
Infection and Drug Resistance 2015, 8:287-296
Published Date: 10 August 2015
Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
Al Alawi S, Abdulkarim S, Elhennawy H, Al-Mansoor A, Al Ansari A
Infection and Drug Resistance 2015, 8:279-285
Published Date: 7 August 2015
Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus
Melendez DP, Razonable RR
Infection and Drug Resistance 2015, 8:269-277
Published Date: 5 August 2015
Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections
Shaikh SBU, Ahmed Z, Arsalan SA, Shafiq S
Infection and Drug Resistance 2015, 8:263-267
Published Date: 31 July 2015
Impact of space flight on bacterial virulence and antibiotic susceptibility
Taylor PW
Infection and Drug Resistance 2015, 8:249-262
Published Date: 30 July 2015
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs
Malone JG
Infection and Drug Resistance 2015, 8:237-247
Published Date: 29 July 2015
Profile and microbiological isolates of asymptomatic bacteriuria among pregnant women in Abakaliki, Nigeria
Onu FA, Ajah LO, Ezeonu PO, Umeora OUJ, Ibekwe PC, Ajah MI
Infection and Drug Resistance 2015, 8:231-235
Published Date: 24 July 2015
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
O’Driscoll T, Crank CW
Infection and Drug Resistance 2015, 8:217-230
Published Date: 24 July 2015
Clinical predictors for severe sepsis in patients with necrotizing fasciitis: an observational cohort study in northern Thailand
Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Tantraworasin A
Infection and Drug Resistance 2015, 8:207-216
Published Date: 16 July 2015
Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience
Hirano R, Sakamoto Y, Kudo K, Ohnishi M
Infection and Drug Resistance 2015, 8:199-205
Published Date: 8 July 2015
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections
Mitra S, Saeed U, Havlichek DH, Stein GE
Infection and Drug Resistance 2015, 8:189-197
Published Date: 6 July 2015
Histopathological changes induced in an animal model by potentially pathogenic Enterococcus faecalis strains recovered from ready-to-eat food outlets in Osun State, Nigeria
Olawale AK, David OM, Oluyege AO, Osuntoyinbo RT, Laleye SA, Famurewa O
Infection and Drug Resistance 2015, 8:181-187
Published Date: 26 June 2015
Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates
El Houfi A, Javed N, Solem CT, Macahilig C, Stephens JM, Raghubir N, Chambers R, Li JZ, Haider S
Infection and Drug Resistance 2015, 8:173-179
Published Date: 18 June 2015
Efinaconazole in the treatment of onychomycosis
Lipner SR, Scher RK
Infection and Drug Resistance 2015, 8:163-172
Published Date: 1 June 2015
Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations
Couldwell DL, Lewis DA
Infection and Drug Resistance 2015, 8:147-161
Published Date: 26 May 2015
Corynebacterium urealyticum: a comprehensive review of an understated organism
Salem N, Salem L, Saber S, Ismail G, Bluth MH
Infection and Drug Resistance 2015, 8:129-145
Published Date: 21 May 2015
Chronic Lyme disease: misconceptions and challenges for patient management
Halperin JJ
Infection and Drug Resistance 2015, 8:119-128
Published Date: 15 May 2015
Polymerase chain reaction-based active surveillance of MRSA in emergency department patients
Seki M, Takahashi H, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Ogura H, Shimazu T, Tomono K
Infection and Drug Resistance 2015, 8:113-118
Published Date: 14 May 2015
Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital
Takahashi H, Seki M, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Toyokawa M, Nishi I, Ogura H, Shimazu T, Tomono K
Infection and Drug Resistance 2015, 8:107-111
Published Date: 14 May 2015
blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria
Akinyemi KO, Iwalokun BA, Alafe OO, Mudashiru SA, Fakorede C
Infection and Drug Resistance 2015, 8:99-106
Published Date: 11 May 2015
Current trends in the prevalence of Cryptococcus gattii in the United States and Canada
Espinel-Ingroff A, Kidd SE
Infection and Drug Resistance 2015, 8:89-97
Published Date: 11 May 2015
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis
AbdulWahab A, Taj-Aldeen SJ, Ibrahim EB, Talaq E, Abu-Madi M, Fotedar R
Infection and Drug Resistance 2015, 8:83-88
Published Date: 30 April 2015
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
Hall RG 2nd, Michaels HN
Infection and Drug Resistance 2015, 8:75-82
Published Date: 22 April 2015
Influence of host resistance on viral adaptation: hepatitis C virus as a case study
Plauzolles A, Lucas M, Gaudieri S
Infection and Drug Resistance 2015, 8:63-74
Published Date: 7 April 2015
Agriculture and food animals as a source of antimicrobial-resistant bacteria
Economou V, Gousia P
Infection and Drug Resistance 2015, 8:49-61
Published Date: 1 April 2015
Lymphogranuloma venereum: diagnostic and treatment challenges
Ceovic R, Jerkovic Gulin S
Infection and Drug Resistance 2015, 8:39-47
Published Date: 27 March 2015
Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital
Kabbara WK, Nawas GT, Ramadan WH
Infection and Drug Resistance 2015, 8:31-38
Published Date: 24 March 2015
The role of dolutegravir in the management of HIV infections
Miller MM, Liedtke MD, Lockhart SM, Rathbun RC
Infection and Drug Resistance 2015, 8:19-29
Published Date: 19 February 2015
The relationship between hand hygiene and health care-associated infection: it’s complicated
McLaws ML
Infection and Drug Resistance 2015, 8:7-18
Published Date: 29 January 2015
Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula
Nakayama T, Ueda S, Huong BTM, Tuyen LD, Komalamisra C, Kusolsuk T, Hirai I, Yamamoto Y
Infection and Drug Resistance 2015, 8:1-5
Published Date: 23 January 2015
Antibiotic lock therapy: review of technique and logistical challenges
Justo JA, Bookstaver PB
Infection and Drug Resistance 2014, 7:343-363
Published Date: 12 December 2014
Current perspectives on the spread of dengue in India
Gupta E, Ballani N
Infection and Drug Resistance 2014, 7:337-342
Published Date: 11 December 2014
Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates?
Yoshida J, Harada Y, Kikuchi T, Asano I, Ueno T, Matsubara N
Infection and Drug Resistance 2014, 7:331-335
Published Date: 1 December 2014
The effect of a unique propolis compound (PropoelixTM) on clinical outcomes in patients with dengue hemorrhagic fever
Soroy L, Bagus S, Yongkie IP, Djoko W
Infection and Drug Resistance 2014, 7:323-329
Published Date: 9 December 2014
Virulence and antimicrobial resistance of Escherichia coli isolated from Tigris River and children diarrhea
Ibrahim IA, Al-Shwaikh RM, Ismaeil MI
Infection and Drug Resistance 2014, 7:317-322
Published Date: 26 November 2014
Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
AbdulWahab A, Taj-Aldeen SJ, Ibrahim E, Abdulla SH, Muhammed R, Ahmed I, Abdeen Y, Sadek O, Abu-Madi M
Infection and Drug Resistance 2014, 7:309-316
Published Date: 20 November 2014
Nosocomial bacteriuria in elderly inpatients may be leading to considerable antibiotic overuse: an audit of current management practice in a secondary level care hospital in New Zealand
Blakiston M, Zaman S
Infection and Drug Resistance 2014, 7:301-308
Published Date: 13 November 2014
Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy
Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA, Chandra P
Infection and Drug Resistance 2014, 7:289-299
Published Date: 6 November 2014
Middle East respiratory syndrome coronavirus: epidemiology and disease control measures
Al-Tawfiq JA, Memish ZA
Infection and Drug Resistance 2014, 7:281-287
Published Date: 3 November 2014
An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C
Infection and Drug Resistance 2014, 7:273-280
Published Date: 24 October 2014
Optimizing antimicrobial therapy in critically ill patients
Vitrat V, Hautefeuille S, Janssen C, Bougon D, Sirodot M, Pagani L
Infection and Drug Resistance 2014, 7:261-271
Published Date: 20 October 2014
Genotypes and phenotypes of Shiga toxin-producing Escherichia coli (STEC) in Abeokuta, Southwestern Nigeria
Olowe OA, Aboderin BW, Idris OO, Mabayoje VO, Opaleye OO, Adekunle OC, Olowe RA, Akinduti PA, Ojurongbe O
Infection and Drug Resistance 2014, 7:253-259
Published Date: 15 October 2014
Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity
Steiner DJ, Furuya Y, Metzger DW
Infection and Drug Resistance 2014, 7:239-251
Published Date: 18 September 2014
Peptidomimetics as a new generation of antimicrobial agents: current progress
Méndez-Samperio P
Infection and Drug Resistance 2014, 7:229-237
Published Date: 30 August 2014
Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis
Dookie N, Sturm AW, Moodley P
Infection and Drug Resistance 2014, 7:223-228
Published Date: 19 August 2014
E. coli O157 outbreaks in the United Kingdom: past, present, and future
Pennington TH
Infection and Drug Resistance 2014, 7:211-222
Published Date: 19 August 2014
Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit
Chittawatanarat K, Jaipakdee W, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T
Infection and Drug Resistance 2014, 7:203-210
Published Date: 16 August 2014
Comparative analysis of the infectivity rate of both Borrelia burgdorferi and Anaplasma phagocytophilum in humans and dogs in a New Jersey community
Gaito A, Gjivoje V, Lutz S, Baxter B
Infection and Drug Resistance 2014, 7:199-201
Published Date: 7 August 2014
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, Chidiac C, Ader F, Ferry T
Infection and Drug Resistance 2014, 7:183-197
Published Date: 5 July 2014
Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M
Infection and Drug Resistance 2014, 7:177-182
Published Date: 27 June 2014
Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
Huddleston JR
Infection and Drug Resistance 2014, 7:167-176
Published Date: 20 June 2014
Epidemiology and disease burden of tuberculosis in children: a global perspective
Seddon JA, Shingadia D
Infection and Drug Resistance 2014, 7:153-165
Published Date: 18 June 2014
Importance of antimicrobial stewardship to the English National Health Service
Dixon J, Duncan CJA
Infection and Drug Resistance 2014, 7:145-152
Published Date: 30 May 2014
Corticosteroids in the treatment of dengue shock syndrome
Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC
Infection and Drug Resistance 2014, 7:137-143
Published Date: 22 May 2014
Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
Rubinstein E, Stryjewski ME, Barriere SL
Infection and Drug Resistance 2014, 7:129-135
Published Date: 20 May 2014
Staphylococcus aureus – antimicrobial resistance and the immunocompromised child
McNeil JC
Infection and Drug Resistance 2014, 7:117-127
Published Date: 7 May 2014
Gold mining areas in Suriname: reservoirs of malaria resistance?
Adhin MR, Labadie-Bracho M, Vreden S
Infection and Drug Resistance 2014, 7:111-116
Published Date: 5 May 2014
Raxibacumab: potential role in the treatment of inhalational anthrax
Kummerfeldt CE
Infection and Drug Resistance 2014, 7:101-109
Published Date: 29 April 2014
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
Hedari CP, Khinkarly RW, Dbaibo GS
Infection and Drug Resistance 2014, 7:85-99
Published Date: 3 April 2014
Long-term efficacy and safety of raltegravir in the management of HIV infection
Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC
Infection and Drug Resistance 2014, 7:73-84
Published Date: 18 March 2014
Community-acquired Clostridium difficile infection: an increasing public health threat
Gupta A, Khanna S
Infection and Drug Resistance 2014, 7:63-72
Published Date: 17 March 2014
Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
Leistner R, Sakellariou C, Gürntke S, Kola A, Steinmetz I, Kohler C, Pfeifer Y, Eller C, Gastmeier P, Schwab F
Infection and Drug Resistance 2014, 7:57-62
Published Date: 13 March 2014
Approaches to hepatitis C treatment and cure using NS5A inhibitors
Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF
Infection and Drug Resistance 2014, 7:41-56
Published Date: 5 March 2014
A case of bacteremia caused by Campylobacter fetus: an unusual presentation in an infant
Alnimr AM
Infection and Drug Resistance 2014, 7:37-40
Published Date: 25 February 2014
Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections
Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL
Infection and Drug Resistance 2014, 7:25-35
Published Date: 18 February 2014
Update on otitis media – prevention and treatment
Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M
Infection and Drug Resistance 2014, 7:15-24
Published Date: 10 January 2014
Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
Saidel-Odes L, Borer A
Infection and Drug Resistance 2014, 7:9-14
Published Date: 10 December 2013
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
Wilke M, Grube R
Infection and Drug Resistance 2014, 7:1-7
Published Date: 18 December 2013
The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae
Miossec C, Claudon M, Levasseur P, Black MT
Infection and Drug Resistance 2013, 6:235-240
Published Date: 3 December 2013
Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria
Onoh RC, Umeora OUJ, Egwuatu VE, Ezeonu PO, Onoh TJP
Infection and Drug Resistance 2013, 6:225-233
Published Date: 2 December 2013
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
Hong MC, Hsu DI, Bounthavong M
Infection and Drug Resistance 2013, 6:215-223
Published Date: 29 November 2013
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco
Zakham F, Chaoui I, Echchaoui AH, Chetioui F, Elmessaoudi MD, Ennaji MM, Abid M, El Mzibri M
Infection and Drug Resistance 2013, 6:207-213
Published Date: 28 November 2013
Prevalence of nontyphoidal Salmonella serogroups and their antimicrobial resistance patterns in a university teaching hospital in Eastern Province of Saudi Arabia
Elhadi N, Aljindan R, Aljeldah M
Infection and Drug Resistance 2013, 6:199-205
Published Date: 22 November 2013
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
Kamali A, Holodniy M
Infection and Drug Resistance 2013, 6:187-198
Published Date: 19 November 2013
Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus
Antonic V, Stojadinovic A, Zhang B, Izadjoo MJ, Alavi M
Infection and Drug Resistance 2013, 6:175-186
Published Date: 6 November 2013
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
Falci DR, Pasqualotto AC
Infection and Drug Resistance 2013, 6:163-174
Published Date: 22 October 2013
Management strategies in the treatment of neonatal and pediatric gastroenteritis
Ciccarelli S, Stolfi I, Caramia G
Infection and Drug Resistance 2013, 6:133-161
Published Date: 29 October 2013
Communicable disease-related sudden death in the 21st century in Nigeria
Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA
Infection and Drug Resistance 2013, 6:125-132
Published Date: 7 October 2013
Whole-genome sequencing in bacteriology: state of the art
Dark MJ
Infection and Drug Resistance 2013, 6:115-123
Published Date: 8 October 2013
The use of platensimycin and platencin to fight antibiotic resistance
Allahverdiyev AM, Bagirova M, Abamor ES, Ates SC, Koc RC, Miraloglu M, Elcicek S, Yaman S, Unal G
Infection and Drug Resistance 2013, 6:99-114
Published Date: 18 September 2013
Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden
Tham J, Odenholt I, Walder M, Andersson L, Melander E
Infection and Drug Resistance 2013, 6:93-97
Published Date: 19 September 2013
Phenotypic and molecular characteristics of methicillin-resistant Staphylococcus aureus isolates from Ekiti State, Nigeria
Olowe OA, Kukoyi OO, Taiwo SS, Ojurongbe O, Opaleye OO, Bolaji OS, Adegoke AA, Makanjuola OB, Ogbolu DO, Alli OT
Infection and Drug Resistance 2013, 6:87-92
Published Date: 20 August 2013
Procalcitonin as a useful marker to decide upon intervention for urinary tract infection
Sugimoto K, Shimizu N, Matsumura N, Oki T, Nose K, Nishioka T, Uemura H
Infection and Drug Resistance 2013, 6:83-86
Published Date: 7 August 2013
Streptococcus group C meningitis with cavernous sinus thrombosis
Clarke M, Enuh H, Saverimuttu J, Nfonoyim J
Infection and Drug Resistance 2013, 6:79-81
Published Date: 7 August 2013
Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana
Donkor ES, Foster-Nyarko E, Enweronu-Laryea CC
Infection and Drug Resistance 2013, 6:71-77
Published Date: 29 July 2013
Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan
Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, Yamamoto A, Yamamoto M, Toyoshima H, Kawakami F, Matsuura N, Yamamoto Y
Infection and Drug Resistance 2013, 6:67-70
Published Date: 22 July 2013
Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcus aureus surveillance: a 60-month study
Yoshida J, Kikuchi T, Matsubara N, Asano I, Ogami N
Infection and Drug Resistance 2013, 6:59-66
Published Date: 23 July 2013
Asymptomatic bacteriuria among elderly and middle-aged rural community-dwellers in South-Western Nigeria
Olowe OA, Makanjuola OB, Olabiyi KO, Akinwusi PO, Alebiosu CO, Isawumi MA, Hassan MB, Asekun-Olarinmoye EO, Adebimpe WO, Adewole TA
Infection and Drug Resistance 2013, 6:55-58
Published Date: 9 July 2013
Emerging therapies for Clostridium difficile infection – focus on fidaxomicin
Chaparro-Rojas F, Mullane KM
Infection and Drug Resistance 2013, 6:41-53
Published Date: 28 June 2013
Invasive Aspergillus infections in hospitalized patients with chronic lung disease
Wessolossky M, Welch VL, Sen A, Babu TM, Luke DR
Infection and Drug Resistance 2013, 6:33-39
Published Date: 27 May 2013
In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide
Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI
Infection and Drug Resistance 2013, 6:27-32
Published Date: 6 March 2013
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Wissing H, Ballus J, Bingold TM, Nocea G, Krobot KJ, Kaskel P, Kumar RN, Mavros P
Infection and Drug Resistance 2013, 6:15-25
Published Date: 30 January 2013
Update on the management of chronic rhinosinusitis
Cain RB, Lal D
Infection and Drug Resistance 2013, 6:1-14
Published Date: 23 January 2013
Current management options for latent tuberculosis: a review
Norton BL, Holland DP
Infection and Drug Resistance 2012, 5:163-173
Published Date: 29 November 2012
Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period
Hughes A, Davies L, Hale R, Gallagher JE
Infection and Drug Resistance 2012, 5:155-161
Published Date: 25 October 2012
Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes
Marí Solivellas B, Cabanes Martín T
Infection and Drug Resistance 2012, 5:149-153
Published Date: 16 October 2012
Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
Tham J, Walder M, Melander E, Odenholt I
Infection and Drug Resistance 2012, 5:143-147
Published Date: 16 October 2012
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
Chen LF, Anderson DJ, Paterson DL
Infection and Drug Resistance 2012, 5:133-141
Published Date: 24 September 2012
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T
Infection and Drug Resistance 2012, 5:129-132
Published Date: 22 August 2012
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
Falsey AR
Infection and Drug Resistance 2012, 5:121-127
Published Date: 8 August 2012
Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005
Ako BA, Offianan AT, Johansson M, Penali LK, Nguetta SP, Sibley CH
Infection and Drug Resistance 2012, 5:113-120
Published Date: 1 August 2012
Treatment of dengue fever
Rajapakse S, Rodrigo C, Rajapakse A
Infection and Drug Resistance 2012, 5:103-112
Published Date: 23 July 2012
Clinical update on linezolid in the treatment of Gram-positive bacterial infections
Ager S, Gould K
Infection and Drug Resistance 2012, 5:87-102
Published Date: 25 June 2012
Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, Mitarai S, Yamada N
Infection and Drug Resistance 2012, 5:79-86
Published Date: 7 May 2012
The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study
Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM
Infection and Drug Resistance 2012, 5:75-78
Published Date: 24 April 2012
High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Stålsby Lundborg C
Infection and Drug Resistance 2012, 5:65-73
Published Date: 5 April 2012
Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire
Offianan AT, Penali LK, Coulibaly MA, Tiacoh NL, Ako AAB, Adji EG, Coulibaly B, Koffi D, Sarr D, Jambou R, Kone M
Infection and Drug Resistance 2012, 5:53-63
Published Date: 12 March 2012
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI
Infection and Drug Resistance 2012, 5:43-51
Published Date: 1 February 2012
Conjunctival sac bacterial flora isolated prior to cataract surgery
Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H
Infection and Drug Resistance 2012, 5:37-41
Published Date: 24 January 2012
Ceftaroline in complicated skin and skin-structure infections
Hernandez PO, Lema S, Tyring SK, Mendoza N
Infection and Drug Resistance 2012, 5:23-35
Published Date: 19 January 2012
Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M
Infection and Drug Resistance 2012, 5:17-21
Published Date: 13 January 2012
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
Miceli MH, Chandrasekar P
Infection and Drug Resistance 2012, 5:9-16
Published Date: 11 January 2012
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Thaiss WM, Thaiss CC, Thaiss CA
Infection and Drug Resistance 2012, 5:1-8
Published Date: 9 January 2012
A necrotic lung ball caused by co-infection with Candida and Streptococcus pneumoniae
Yokoyama T, Sasaki J, Matsumoto K, Koga C, Ito Y, Kaku Y, Tajiri M, Natori H, Hirokawa M
Infection and Drug Resistance 2011, 4:221-224
Published Date: 15 December 2011
Resistance to antimicrobial drugs in Ghana
Newman MJ, Frimpong E, Donkor ES, Opintan JA, Asamoah-Adu A
Infection and Drug Resistance 2011, 4:215-220
Published Date: 21 December 2011
An Enterobacter plasmid as a new genetic background for the transposon Tn1331
Alavi MR, Antonic V, Ravizee A, Weina PJ, Izadjoo M, Stojadinovic A
Infection and Drug Resistance 2011, 4:209-213
Published Date: 28 November 2011
Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public
Nguyen T, Holdt Henningsen K, Brehaut JC, Hoe E, Wilson K
Infection and Drug Resistance 2011, 4:197-207
Published Date: 20 October 2011
Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
Honda R, Toshida H, Suto C, Fujimaki T, Kimura T, Ohta T, Murakami A
Infection and Drug Resistance 2011, 4:191-196
Published Date: 20 October 2011
Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy
Bush LM, Chaparro-Rojas F, Okeh V, Etienne J
Infection and Drug Resistance 2011, 4:177-189
Published Date: 18 October 2011
Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran
Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N
Infection and Drug Resistance 2011, 4:171-176
Published Date: 11 October 2011
Meningococcal conjugate vaccines: optimizing global impact
Terranella A, Cohn A, Clark T
Infection and Drug Resistance 2011, 4:161-169
Published Date: 21 September 2011
Review of oral cholera vaccines: efficacy in young children
Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN
Infection and Drug Resistance 2011, 4:155-160
Published Date: 14 September 2011
Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital
Oliveira PR, Paula AP, Dal-Paz K, Felix CS, Rossi F, Silva JS, Lima ALM
Infection and Drug Resistance 2011, 4:149-154
Published Date: 4 August 2011
Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease
Bröker M, Cooper B, DeTora LM, Stoddard JJ
Infection and Drug Resistance 2011, 4:137-147
Published Date: 22 July 2011
Treatment of drug-resistant tuberculosis
Pinto LM, Menzies D
Infection and Drug Resistance 2011, 4:129-135
Published Date: 21 July 2011
Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
White B, Seaton RA
Infection and Drug Resistance 2011, 4:115-127
Published Date: 24 May 2011
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, Rossi M, Stricker RB
Infection and Drug Resistance 2011, 4:97-113
Published Date: 3 May 2011
Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
Lida Jafari Saraf, Samuel Eric Wilson
Infection and Drug Resistance 2011, 4:87-95
Published Date: 10 March 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
Mary L Townsend, Melanie W Pound, Richard H Drew
Infection and Drug Resistance 2011, 4:77-86
Published Date: 2 March 2011
Patterns of resistance development with integrase inhibitors in HIV
Jean L Mbisa, Supang A Martin, Patricia A Cane
Infection and Drug Resistance 2011, 4:65-76
Published Date: 22 February 2011
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
Melissa Osborn
Infection and Drug Resistance 2011, 4:55-64
Published Date: 3 February 2011
Update on the optimal use of voriconazole for invasive fungal infections
Asma Lat George R Thompson III
Infection and Drug Resistance 2011, 4:43-53
Published Date: 3 February 2011
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
Roger Sordé, Albert Pahissa, Jordi Rello
Infection and Drug Resistance 2011, 4:31-41
Published Date: 25 January 2011
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges
Brandie D Taylor, Catherine L Haggerty
Infection and Drug Resistance 2011, 4:19-29
Published Date: 20 January 2011
Current treatment of choice for chronic hepatitis C infection
Tareq Yasin, Thomas R Riley, Ian R Schreibman
Infection and Drug Resistance 2011, 4:11-18
Published Date: 12 January 2011
Lyme disease: the next decade
Raphael B Stricker, Lorraine Johnson
Infection and Drug Resistance 2011, 4:1-9
Published Date: 7 January 2011
Current strategies for the prevention and management of central line-associated bloodstream infections
Zhuolin Han, Stephen Y Liang, Jonas Marschall
Infection and Drug Resistance 2010, 3:147-163
Published Date: 23 November 2010
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
Josep Quer, Maria Buti, Maria Cubero, et al
Infection and Drug Resistance 2010, 3:133-145
Published Date: 23 November 2010
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
Martha K Daddario, Jennifer K Hagerman, Michael E Klepser
Infection and Drug Resistance 2010, 3:123-132
Published Date: 28 October 2010
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective
BM Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, et al
Infection and Drug Resistance 2010, 3:115-122
Published Date: 22 October 2010
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
Charlotte Charpentier, Laurence Weiss
Infection and Drug Resistance 2010, 3:103-114
Published Date: 13 October 2010
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
Andres Beiras-Fernandez, Ferdinand Vogt, Ralf Sodian, et al.
Infection and Drug Resistance 2010, 3:95-101
Published Date: 30 August 2010
Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al
Infection and Drug Resistance 2010, 3:87-94
Published Date: 19 August 2010
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Alicia I Hidron, Russell Kempker, Abeer Moanna, et al
Infection and Drug Resistance 2010, 3:73-86
Published Date: 6 August 2010
The use of anti-tuberculosis therapy for latent TB infection
Justin T Denholm, Emma S McBryde
Infection and Drug Resistance 2010, 3:63-72
Published Date: 21 July 2010
Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change
J Mebis, H Jansens, G Minalu, et al
Infection and Drug Resistance 2010, 3:53-61
Published Date: 28 July 2010
Role of posaconazole in the treatment of oropharyngeal candidiasis
Voichita Ianas, Kathryn R Matthias, Stephen A Klotz
Infection and Drug Resistance 2010, 3:45-51
Published Date: 28 June 2010
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
Lorenzo Aguilar, María-José Giménez, José Barberán
Infection and Drug Resistance 2010, 3:35-43
Published Date: 18 June 2010
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Whitney P Caron, Shaker A Mousa
Infection and Drug Resistance 2010, 3:25-33
Published Date: 21 May 2010
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
Lisa M Chirch, Roy T Steigbigel
Infection and Drug Resistance 2010, 3:15-23
Published Date: 26 April 2010
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
César Bustos, Jose L Del Pozo
Infection and Drug Resistance 2010, 3:5-14
Published Date: 22 April 2010
Respiratory failure caused by intrathoracic amoebiasis
Toshinobu Yokoyama, Masashi Hirokawa, Yutaka Imamura, et al
Infection and Drug Resistance 2010, 3:1-4
Published Date: 11 March 2010
Anidulafungin and its role in candida infections
Diane M Cappelletty, Rose Jung
Infection and Drug Resistance 2009, 2:51-60
Published Date: 30 June 2009
Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections
Tze Shien Lo, Stephanie M Borchardt, Justin M Welch, Melissa A Rohrich, Augusto M Alonto, Anne V Alonto
Infection and Drug Resistance 2009, 2:41-49
Published Date: 30 June 2009
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus
William J Peppard, Anne Daniels, Lynne Fehrenbacher, Jamie Winner
Infection and Drug Resistance 2009, 2:27-40
Published Date: 8 June 2009
New approaches in the management of chronic hepatitis B: role of tenofovir
Jurriën GP Reijnders, Harry LA Janssen
Infection and Drug Resistance 2009, 2:13-26
Published Date: 24 April 2009
The determinants of the antibiotic resistance process
Beatriz Espinosa Franco, Marina Altagracia Martínez, Martha A Sánchez Rodríguez, Albert I Wertheimer
Infection and Drug Resistance 2009, 2:1-11
Published Date: 17 April 2009
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
Nathan P Wiederhold, Jason M Cota, Christopher R Frei
Infection and Drug Resistance 2008, 1:63-77
Published Date: 12 January 2009
High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India
Hare Krishna Tiwari, Darshan Sapkota, Malaya Ranjan Sen
Infection and Drug Resistance 2008, 1:57-61
Published Date: 30 November 2008
Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
Somvadee Laohavaleeson, Karen Lolans, John P Quinn, Joseph L Kuti, David P Nicolau
Infection and Drug Resistance 2008, 1:51-55
Published Date: 23 November 2008
Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco
Hayat Ennaji, Mohammed Timinouni, My Mustapha Ennaji, Mohammed Hassar, Nozha Cohen
Infection and Drug Resistance 2008, 1:45-50
Published Date: 28 September 2008
Current and novel antibiotics against resistant Gram-positive bacteria
Federico Perez, Robert A Salata, Robert A Bonomo
Infection and Drug Resistance 2008, 1:27-44
Published Date: 9 September 2008
New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice
Nora Morcillo, Belén Imperiale, Juan Carlos Palomino
Infection and Drug Resistance 2008, 1:21-26
Published Date: 20 August 2008
Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children
Hafid Belhadj-Tahar, Yvon Coulais, Mathieu Tafani, François Bouissou
Infection and Drug Resistance 2008, 1:17-20
Published Date: 12 August 2008
Pilonidal sinus of the penis
H Al Chalabi, H A Ghalib, M Nabri, T O’Hanrahan
Infection and Drug Resistance 2008, 1:13-15
Published Date: 6 August 2008
Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
Christy A Beneri, David P Nicolau, Howard S Seiden, Lorry G Rubin
Infection and Drug Resistance 2008, 1:9-11
Published Date: 12 August 2008
Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics
Shih-Wei Yang, Ming-Hsun Lee, Lai-Chu See, Shu-Huan Huang, Tsung-Ming Chen, Tai-An Chen
Infection and Drug Resistance 2008, 1:1-8
Published Date: 7 July 2008